W m WWW“ WWI ‘ {m 3 1293 00809 6830 1V4E3I_] RETURNING MATERIALS: P1ace in book drop to LJBRARJES remove this checkout from man—n. your record. FINES win be charged if book is returned after the date stamped below. EFFECTS OF ANTIBIOTICS ON DEPOLARIZATION-INDUCED Ca2+ UPTAKE INTO SYNAPTOSOMES BY Carol M. Beaman A THESIS Submitted to Michigan State University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Department of Pharmacology and Toxicology 1986 ABSTRACT EFFECTS OF AQIIBIOTICS ON DEPOLARIZATION-INDUCED Ca UPTAKE INTO SYNAPTOSOMES BY Carol M. Beaman Antibiotics of four classes block neuromuscular transmission by a combination of pre- and postjunctional effects. The prejunctional effects may involve competitive 2+ block of Ca entry into the nerve terminal. This has never been tested directly, however. The goal of the present study was to determine if antibiotics known to block neuromuscular transmission would impair depolarization-dependent uptake of calcium into isolated nerve terminals (synaptosomes). Drugs were applied in concentrations ranging from 1 - 1000 uM. 45 Uptake of Ca was determined during K+-stimulated depolarization (K+ = 77.5 mM). Both the fast and slow phases 2+ of Ca influx, along with total influx were measured. Neomycin (500 and 1000 uM) decreased fast phase Ca2+ uptake. Oxytetracycline (1000 uM) decreased total and both phases of Ca2+ uptake. Polymyxin B (5 uM) increased fast phase uptake, while 500 and 1000 uM decreased total and slow phase Ca2+ uptake. The decrease in fast phase Ca2+ uptake caused by oxytetracycline and neomycin was reversed by increasing the external calcium concentration. These results indicate that several antibiotics which cause neuromuscular block can alter depolarization-induced calcium uptake into synaptosomes at high concentrations. ACKNOWLEDGMENTS I would like to thank the members of my committee, Drs. Brody, Hume and Thornburg, for their time and guidance. To all the people in the Pharmacology department, especially, Roseann Vorce, Paul Levesque and Corie Pawloski, who made the time I spent at MSU more enjoyable; Thanks! A special thanks to Lonnie Dahm for being there when I needed someone. To Dr. Atchison, my advisor, I owe my deepest thanks for believing in me and giving me a chance to realize my goals. Finally, to my husband Mark, without whose love, patience and understanding this would not have been possible, my sincere appreciation. 1°1- TABLE OF CONTENTS List of Tables..................................... v List of Figures.................................... vi Introduction....................................... 1 Antibiotic Induced Neuromuscular Block........ 1 Actions, Uses and Side Effects of Antibiotics That Cause Neuromuscular Block................ 2 Neuromuscular Transmission.................... 5 NeuromuSCUlar BIOCk...OOOOOOOOOOOOOOOOOOOOOOOO 7 A) Mechanism of Antibiotic Induced Neuromuscular Block..................... 8 B) Postjunctional Neuromuscular Block...... 11 C) Prejunctional Neuromuscular Block....... 12 Calcium Channels.............................. 13 A) Multiple Types of Calcium Channels...... 14 B) Calcium Channel Block................... 15 C) Calcium Channel Inactivation............ 17 Competitive Antagonism -- a possible mechanism 18 Synaptosomes.................................. 21 Calcium Uptake into Synaptosomes.............. 23 Experimental Rationale........................ 26 Method and Materials............................... 29 Solutions and Chemicals....................... 33 Statistical Analysis.......................... 34 ReSUItSOCOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO000...... 35 Uptake of Ca2+ into Synaptosomes.............. 35 2+ Total ca UptakeOOCOOOCOOOOOOOOOOO0.0.00.0... 42 2+ Fast Phase of Ca Uptake..................... 51 2+ Slow Phase of Ca Uptake..................... 60 The Effectszof Antibiotics on Baseline (Low K ) Ca uptake.......................... 69 Summary -- Concentration Response............. 70 calCium Reversal. O O O O O O O O O O O O O O O O O O O O I O O O O O O O O 77 DiscuSSion...OOOOOOOOOOOOOOOOO ..... OOOOOOOOOOOOO... 88 List Of ReferenceSOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO 100 iv LIST OF TABLES Significant effects of antibigtics on net K+- stimulated (77.5 mM) total Ca uptake (10 sec incubation) into synaptosomes.................. Significant effects of antibiotics on net K+- stimulated (77.5 mM) fast (1 sec incubation) and slow phase (10 seS+incubation after predepolarization) Ca uptake into synaptosomes................................... Control values and values for each AB concentration that caused a statistically significant change 'n net K -stimulated (77.5 mM) total Ca uptake (10 sec incubation) into synaptosomes. The values are expressed as fmoles Ca uptake/ug protein 1 SEM............ Control values and values for each AB concentration that caused a statistically significant change in net K -stimulated (77.5 mM) fast phase (1 sec incubation) and slow phase (10 sec inSubation after predepolarization) Ca uptake into 2+ synaptosomes, expressed as fmoles Ca uptake/ug protein : SEM........................ 78 79 80 81 10. ll. 12. LIST OF FIGURES Structures of four antibiotic that block neuromuscular transmission..................... Structures of some agents that modify calcium Channel actiVitYOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOC Preparation Of synaptosomes....COCOOCOOOOOOOOOO Dependence of Ca2+ uptake by depolarized synaptosomes, on duration of depolarization.... Potassium-stimulated (77.5 mM) Ca2+ uptake by different concentrations of synaptosomes (protein)......OOOOIOOOOOOOOOOOOOOOOOOOOOOOOOOO Ca2+ uptake by depolarized synaptosomes (772; mM potassium solution) as a function of [Ca ] ........................................ Ca2+ uptake by potassium-depolarized (77.5 mM) synaptosomes in the presence of various concentrations of lead......................... Total Ca2+ uptake (10 sec incubation) by potassium-depolarized (77.5 mM) synaptosomes in the presence of neomycin (1 - 1000 uM)......... Total Ca2+ uptake (10 sec incubation) by potassium-depolarized (77.5 mM) synaptosomes in the presence of clindamycin (1 - 1000 uM)...... Total Ca2+ uptake (10 sec incubation) by potassium-depolarized (77.5 mM) synaptosomes in the presence of oxytetracycline (1 - 1000 uM).. Total Ca2+ uptake (10 sec incubation) by potassium-depolarized (77.5 mM) synaptosomes in the presence of polymyxin (1 - 1000 uM)........ Fast phase Ca2+ uptake (1 sec incubation) by potassium-depolarized (77.5 mM) synaptosomes in the presence of neomycin (1 - 1000 uM)......... vi 16 30 36 38 39 41 44 46 48 50 53 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. Fast phase Ca2+ uptake (1 sec incubation) by potassium-depolarized (77.5 mM) synaptosomes in the presence of oxytetracycline (l - 1000 uM).. Fast phase Ca2+ uptake (1 sec incubation) by potassium-depolarized (77.5 mM) synaptosomes in the presence of polymyxin (1 - 1000 uM)........ Fast phase Ca2+ uptake (1 sec incubation) by potassium-depolarized (77.5 mM) synaptosomes in the presence of clindamycin (1 - 1000 uM)...... Slow phase Ca2+ upta e (10 sec incubation after predepolarization; K = 77.5 mM, no calcium) by potassium-depolarized (77.5 mM) synaptosomes in the presence of neomycin (l - 1000 uM)......... Slow phase Ca2+ upta e (10 sec incubation after predepolarization; K = 77.5 mM, no calcium) by potassium-depolarized (77.5 mM) synaptosomes in the presence of oxytetracycline (l - 1000 uM).. Slow phase Ca2+ upta e (10 sec incubation after predepolarization; K = 77.5 mM, no calcium) by potassium-depolarized (77.5 mM) synaptosomes in the presence of polymyxin (l - 1000 uM)........ Slow phase Ca2+ upta e (10 sec incubation after predepolarization; K = 77.5 mM, no calcium) by potassium-depolarized (77.5 mM) synaptosomes in the presence of clindamycin (1 - 1000 uM)...... A comparison of baseline (K+ = 5 mM) Ca2+ uptake du ing a 10 sec incubation (solid barsi+ and net K -stimulated (K = 77.5 mM) total Ca uptake (striped bars) into synaptosomes........ A comparison of baseline (K+ = 5 mM) Ca2+ uptake du ing a 1 sec incubation (solid bars) an§+net K -stimulated (K = 77.5 mM) fast phase Ca uptake (striped bars) into synaptosomes... A comparison of baseline (K+ = 5 mM) Ca2+ uptake during a 10 sec incubation after p edepolarization (solid bars) and net 2+ K -stimu1ated (K = 77.5 mM) slow phase Ca uptake (striped bars) into synaptosomes........ vii 55 57 59 62 64 66 68 72 74 76 23. 24. Fast phase Ca2+ uptake (1 sec incubation) by potassium-depolarized (77.5 mM) synaptosomes in the presence of 1000 uM oxytetracycline (squares) or drug-free control (circles), at various external calcium concentrations (0.05 - 1.0 mM)................................ Fast phase Ca2+ uptake (1 sec incubation) by potassium-depolarized (77.5 mM) synaptosomes in the presence of 1000 uM neomycin (squares) or drug-free control (circles) at various external calcium concentrations (0.05 - 0.5 mM)......... viii 84 86 INTRODUCTION Antibiotic-Induced Neuromuscular Block Neuromuscular block is a recognized clinical side effect when using some antibiotics (ABs) of the a) aminoglycoside, b) lincosamide, c) polymyxin and d) tetracycline classes (Pittinger gt gt, 1970; Pittinger and Adamson, 1972). Prolonged respiratory depression may occur when ABs are used in conjunction with general anesthetics (eg. enflurane, halothane, isoflurane, nitrous oxide) or neuromuscular blockers (eg. d-tubocurarine, pancuronium, succinylcholine) (Pittinger gt gt, 1970; Pittinger and Adamson, 1972; Fogdall and Miller, 1974), in patients with pre-existing neuromuscular (Pittinger gt gt, 1970) or renal disease, or in patients with electrolyte imbalance (eg. hypocalcemia). Reversal of AB-induced neuromuscular block clinically involves increasing the concentration of Ca2+ or giving neostigmine, but sometimes these regimens are not effective (Pittinger gt gt, 1970). Since it has been reported that the death rate is approximately 9% in patients experiencing respiratory problems related to AB-induced neuromuscular block (Pittinger gt gt, 1970), it is important to determine the mechanism by which ABs block neuromuscular 1 transmission, and thus find ways to prevent or counteract their life threatening actions. Actions, Uses, and Side Effects gt Antibiotics That Cause Neuromuscular Block Although ABs of the four classes all cause neuromuscular block, their structures (figure 1) and antibacterial actions are different. The aminoglycosides and tetracyclines prevent bacterial growth by inhibition of protein synthesis. The aminoglycosides inhibit protein synthesis by preventing peptide initiation, by binding to the 30 S ribosomal subunit and they may also induce misreading of the genetic code (Luzzatto gt gt, 1969; Pestka, 1971; Hash 1972; Sanders and Sanders, 1979). The tetracyclines inhibit protein synthesis by interfering with binding of the aminoacyl-tRNA to the acceptor site, thus inhibiting elongation of the peptide chain (Pestka, 1971; Bash 1972; Sanders and Sanders, 1979). The lincosamides produce their antibacterial action by binding to the 50 S subunit of the bacterial ribosome, leading to inhibition of the peptidyl transferase reaction (Hash, 1972; Sanders and Sanders, 1979). Polymyxins produce their antibacterial actions by competitively displacing Mg2+ or Ca2+ from phosphate groups on membrane lipids, disrupting the normal packing of these lipids and thus changing the membrane permeability (Storm gt gt, 1977; Sanders and Sanders, 1979). .codmmwsmcauu unasom=EOunoc xoo~n saga acquo«nquco u20u uo nousuoauum .a ousawm a 2.3282 N22 20 o: 2&6 « §u< 2553225993. u 202 o a 2.x>z>._o._ . au<¢5;xo 2 o: . a 2w1|22lly 6-6-2 . 2 2 The four classes of ABs that cause neuromuscular block have widely divergent clinical uses (Gilman gt gt, 1985). For example, aminoglycosides are used primarily for treatment of infections due to gram-negative bacteria. Examples of these uses include topical application for burns and wounds, preparation of patients for bowel surgery and treatment of patients with tuberculosis. Lincosamides can be used for infections due to gram-positive cocci; examples of their uses are treatment of abdominal and lung abscesses and pneumonia. Polymyxins may be used for infections due to gram-negative bacteria; examples of their uses include urinary tract infections and topical use for infections of the skin, eyes and ears. Examples of the clinical uses of tetracycline include Rocky Mountain spotted fever, and urinary and ocular infections. Since these ABs have different structures, mechanisms of action and uses, it is not surprising that they produce different side effects as well (Gilman gt gt, 1985). The primary side effects of the aminoglycosides include vestibular, cochlear and renal toxicity. The tetracyclines can cause hepatic and renal toxicity, and gastrointestinal irritation. In addition, tetracyclines have effects on calcified tissues (eg, deposition in teeth and bones). Clindamycin may cause development of pgeudomembranous colitis, which may be lethal. Renal toxicity is the most significant side effect of polymyxin B. Other side effects of polymyxin B include facial flushing, dizziness, slurred speech and blurred vision. Despite the differences in chemical structure, antibacterial mechanism, clinical uses and side effects, these ABs all have one feature in common: they block neuromuscular transmission. Neuromuscular Transmission Neuromuscular transmission is comprised of several steps beginning with synthesis of the neurotransmitter acetylcholine (ACh) and ending with its hydrolysis to stop its effects on the postjunctional membrane and thus terminate its action. ACh is synthesized in the nerve terminal from choline and acetyl CoA in a reaction catalyzed by the enzyme choline acetyltransferase (Dauterman and Mehrotra, 1963; Currier and Mautner, 1974). In the terminal, ACh is stored in synaptic vesicles, although there may be a nonvesicular fraction as well (De Robertis and Bennett, 1955; Collier and MacIntosh, 1969; Ritchie and Goldberg, 1970). Neurotransmitters, including ACh, are thought to be released in discrete amounts (quanta) (Del Castillo and Katz, 1954). After the depolarization of the action potential invades the presynaptic terminal, synaptic vesicles fuse with the membrane to release neurotransmitter by exocytosis (Heuser, 1977; Heuser, gt gt, 1974, 1979). The release of neurotransmitter is dependent on 2+ extracellular Ca (Katz and Miledi 1965b; 1967; 1969; Dodge and Rahamimoff, 1967); somehow depolarization-induced Ca2+ 6 entry into the presynaptic nerve terminal leads to release of neurotransmitter (Llinas and Nicholson, 1975), but the exact mechanism is unknown. A proposed role of calcium is to open Ca2+-activated k+ channels present in synaptic vesicles, thus causing osmotic changes that would lead to fussion of the vesicle with the membrane and exocytosis of the vesicle contents (Stanley and Ehrenstein, 1985). The estimated time required for calcium entry and neurotransmitter release is approximately 200-500 usec (Parsegian, 1977; Llinas gt gt, 1981b). After ACh is released from the presynaptic terminal, it crosses the synaptic cleft. When ACh reaches the postjunctional membrane it binds to the acceptor sites on a macromolecule known as the ACh receptor. This leads to a change in ion permeabilities in the postsynaptic membrane (Takeuchi and Takeuchi, 1960 Katz and Miledi, 1972). The changes in the postsynaptic membrane potential, in turn, cause generation of an action potential in the muscle, which leads to contraction of the muscle. The action of ACh is terminated by acetylcholinesterase which hydrolyzes the ACh to choline and acetate (Collier, 1977). Choline re-enters the nerve terminal by a carrier-mediated process and is reused to make ACh (Marchbanks, 1968, 1982; Diamond and Kennedy, 1969). The entire process of neurotransmitter release from depolarization to the appearance of the postsynaptic end- plate current occurs in milliseconds (msec) (Katz and Miledi, 1965a). The times of each individual synaptic delay 7 are not equal but fall in the range of 0 - 4 msec with a peak in the distribution at 0.75 msec (Katz and Miledi, 1965a). Neuromuscular Block ABs can theoretically block neuromuscular transmission at several sites these include: 1) conduction of the action potential into the nerve terminal, 2) synthesis, mobilization and release of neurotransmitter, 3) activation of the postsynaptic receptor, 4) generation and propagation of the action potential in the muscle membrane, and 5) excitation - contraction coupling in the muscle. The mechanism(s) by which ABS produce neuromuscular block is/are unknown even though numerous experimental studies have been undertaken in an attempt to study this effect (for example, Elmqvist and Josefsson, 1962; Brazil and Corrado, 1969; Wright and Collier, l976a,b, 1977; Prado gt gt, 1978; Singh gt gt, 1978, 1979, 1982; Fiekers gt gt, 1979, 1983; Fiekers, 1981, 1983a,b). The techniques that have been used include; twitch tension measurements following electrical stimulation of motor axons or myofibers from different nerve/muscle preparations, (Becker and Miller, 1976; Wright and Collier, 1976a, 1977; Singh gt gt, 1978), intracellular recordings of postsynaptic potentials and action potentials from isolated nerve/muscle or nerve preparations, respectively (Singh gt gt, 1979, 1982; Caputy gt gt, 1981) and measurements of endplate ionic currents using voltage clamp techniques (Fiekers gt gt, 1979, 1983; Fiekers, 1981, l983a,b; Farley gt gt, 1982). These various studies have demonstrated two types of neuromuscular block caused by ABS: 1) postjunctional i.e. effects on the end-plate receptor or ionic channel (with d-tubocurarine as the prototype), and 2) prejunctional i.e. effects on the release of the neurotransmitter (with magnesium as the prototype). Postjunctional effects have been demonstrated as a decrease in the amplitude of miniature endplate potentials (MEPPs) or currents (MEPCs), a decrease in the amplitude of endplate potentials (EPPs) or currents (EPCs), or non-linearity in the endplate current-voltage relationship. Prejunctional actions of ABs have been demonstrated as a decrease in the amount of neurotransmitter released by a nerve impulse (mean quantal content, 3). However for many ABs the effects cannot be classified as solely ”curare - like“ or "magnesium - like" (Singh gt gt, 1978); these ABs often produce a combination of effects. A) Mechanisms gt Antibiotic Induced Neuromuscular Block The aminoglycosides are thought to possess a combination of pre- and postjunctional blocking actions, with prejunctional effects predominating (Elmqvist and Josefsson, 1962; Brazil and Corrado, 1969; Pittinger and Adamson 1972; Singh gt gt, 1979, 1982; Sokoll and Gergis, 1981; Farley gt gt, 1982; Fiekers, 1983a,b). This has been shown in combined studies of pre- and postjunctional effects of aminoglycosides using a two microelectrode voltage clamp of normal or transected twitch fibers of frog (Farley gt gt, 1982) or snake (Fiekers, 1983a,b), respectively. Neomycin and streptomycin both decreased m, as determined by the ratio of EPC/MEPC amplitude, at concentrations much lower than those which cause postjunctional reduction of MEPC amplitude or alteration of decay kinetics of the EPC. The effect of neomycin in particular was more prominent on prejunctional processes (Fiekers, l983a). The lincosamides, clindamycin and lincomycin, may cause neuromuscular block by a variety of mechanisms including a direct action on the muscle or by postjunctional block of receptor channels. In addition clindamycin may cause neuromuscular block by suppression of ACh release. Lincomycin and clindamycin cause a parallel decrease in muscle contractile response due to nerve stimulation and direct muscle stimulation (Wright and Collier, 1976a). This leads to the conclusion that a myogenic component of block exists. Lincomycin and clindamycin also decrease EPP or EPC amplitude and endplate sensitivity to exogenously applied ACh (Tang and Schroeder, 1968; Becker and Miller, 1976; Rubbo gt gt, 1977; Singh gt gt, 1979, 1982; Fiekers gt gt, 1983), leading to the conclusion that lincosamides act postjunctionally. Although there is much disparity in experimental data, there is evidence that clindamycin may 10 also have prejunctional effects. Clindamycin has variously been described to increase ACh release induced by nerve stimulation (Rubbo gt gt, 1977), decrease quantal content (Fiekers gt gt, 1983), and increase frequency of occurrence of spontaneous MEPPs (Rubbo gt gt, 1977). Polymyxin B has both pre- and post-junctional effects, but postjunctional effects predominate. This is shown by reductions in quantal content similar to those caused by Mg2+ at high concentrations, and decreases in MEPP or MEPC amplitude at very low concentrations (Singh gt gt, 1979, 1982; Fiekers, 1981; Sokoll and Gergis, 1981). The effects of tetracyclines on neuromuscular transmission are less well studied. Wright and Collier (1976b) showed that tetracyclines produced an initial augmentation and subsequent inhibition of muscle contraction in response to nerve stimulation. However, using a phrenic nerve-diaphram preparation they showed that the concentration required to block the response to ACh injection (via the inferior vena cava) was considerably less than the concentration required to block the response to nerve stimulation, suggesting that tetracycline causes neuromuscular block by acting postjunctionally. In opposition to this, Singh gt gt (1982) suggested that tetracycline may have predominantly prejunctional blocking activity along with actions that block muscle contractility. Singh gt gt (1982), used isolated frog sciatic nerve- sartorius muscle preparations to show that tetracycline, 11 like Mgz+ , did not decrease the MEPP amplitude, suggesting that tetracycline does not act postjunctionally. They also showed that tetracycline and oxytetracycline reduced both the maximum rate of rise and fall of action potentials in the muscle, suggesting again a direct myogenic action. B) Postjunctional Neuromuscular Block Despite the fact that ABs act at both pre- and post- junctional sites, the majority of experimental studies have focused on the postjunctional actions. ABs may cause one or more of the following postjunctional effects: block of receptor occupation by ACh, block of ion permeation through the receptor-activated ionic channels, inhibition of action potential prOpagation in the muscle, or disruption of muscle contractility. For example, lincomycin has been shown to interfere with muscle membrane excitation or muscle contraction (Wright and Collier, 1976a). Clindamycin and lincomycin each interact with the open state of the endplate receptor/channel complex in a noncompetitive manner (Fiekers gt gt, 1983). Streptomycin has mixed competitive and noncompetitive actions (Brown and Taylor, 1983), but the predominate postjunctional action is competitive block of the ACh receptor (Farley gt gt, 1982). Neomycin also exerts mixed competitive and noncompetitive actions, with the noncompetitive block of the ACh receptor predominating (Brown and Taylor, 1983). At higher concentrations, 12 neomycin reacts with the receptor channel when it is in an open configuration (Fiekers, 1983b). Polymyxin B interacts in a noncompetitive manner (Brown and Taylor, 1983) with the receptor/channel complex to produce a voltage-dependent block of the open channel (Fiekers, 1981). C) Prejunctional Neuromuscular Block Whereas the postjunctional blocking actions of ABS have been studied extensively, the prejunctional blocking actions of ABS have been studied incompletely. Drugs that have prejunctional effects can act on action potential propagation, neurotransmitter synthesis or release. More specifically ABs may ultimately block neurotransmission presynaptically by any of several mechanisms, such as l) decreasing the calcium concentration in the external medium (by binding calcium, or altering the ionized to nonionized ratio), 2) blocking calcium from entering the nerve terminal (by blocking or inactivating the voltage-dependent calcium channel, 3) altering stimulus/secretion coupling, or 4) affecting neurotransmitter release (decreasing the size of a quantum, or altering the permeability of the membrane). There is evidence based on individual ABS for or against some of these possibilities. However, the effects of none of the ABS have been studied in sufficient detail to determine their mechanism of action, nor has a general mechanism responsible for prejunctional block been proven 13 for all ABS. For example, in the presence of streptomycin (Pittinger, 1970; Tamaki, 1983) or neomycin (Elmqvist and Josefsson, 1962; Wright and Collier, 1977) the concentration of the ionized form of calcium is not changed. These studies have excluded the possibility of calcium binding to the ABS as the mechanism of neuromuscular block. However, it has been postulated that tetracycline's mechanism of action is calcium chelation, with a resultant decrease in neurotransmitter release (Pittinger and Adamson, 1972). This does not seem likely Since Wright and Collier (l976b) have shown that rolitetracycline did not decrease evoked release of ACh; a decrease would be expected if tetracycline acted by chelating calcium. Furthermore, Bowen and McMullan (1975) have shown (in horses) that calcium binding does not seem to contribute to the neuromuscular block produced by oxytetracycline. Clindamycin may have prejunctional effects due to its local anesthetic-like actions (Wright and Collier, l976a). However, these only occur at very high concentrations and thus are unlikely to contribute significantly to the clinically observed effect. Calcium Channels One potential prejunctional mechanism by which ABS may act is to block Ca2+ entry through voltage-regulated calcium channels. Calcium channels are found in all excitable membranes, such as nerve and cardiac muscle membranes. 14 Calcium channels play a role in coupling membrane excitation to cellular responses, eg. secretion or contraction. Calcium channels are also essential for the rhythmic firing of nerve cells (Llinas and Sugimori, 1980). Calcium entry contributes to other neuronal functions such as neurite extension (Anglister gt gt, 1981), generation of dendritic calcium spikes (Llinas and Yarom, 1981) and calcium- dependent potassium conductances (Barrett and Barrett, 1976; Krnjevic gt gt, 1975, 1978; Llinas and Sugimori, 1980). In a variety of cells, depolarization of the membrane increases the membrane's permeability to calcium, i.e. these cells have voltage-dependent calcium channels. A) Multiple Types gt Calcium Channels The different functions of Ca2+ suggest different or multiple types of calcium channels may exist. Two distinct populations of calcium channels have been demonstrated in a clonal cell line derived from rat pituitaries (GH3 cells) based on their closing kinetics (Armstrong and Matteson, 1985). Two distinct types of voltage-activated calcium conductances have also been found in the unfertilized egg of Neanthes arenaceodentata, (Fox and Krasne, 1981), and Mediaster aequalis (Hagiwara gt gt, 1975), suggesting the presence of two calcium channels. Fishman and Specter (1981), working with neuroblastoma (NlE-115), have shown that the decay of the calcium currents exhibits two time 15 constants, which again suggests the existence of two calcium channels. Tsunoo gt gt (1984) have demonstrated two different types of calcium channels in neuroblastoma cells (NlE-llS), based on difference in gating properties and insensitivity to cyclic AMP. Nowycky gt gt (1985), have demonstrated three types of calcium channels in dorsal root ganglion cells. Two types of calcium channels have been proposed to exist in synaptosomes (Nachshen and Blaustein, 1980). Recently, Penner and Dreyer (1986) have presented evidence suggesting the presence of multiple type of calcium channels in the motor nerve terminal at the mouse neuromuscular junction. Thus, results from many different preparations suggest the existence of multiple Ca2+ channels. B) Calcium Channel Blockers Calcium channels are blocked by a number of agents (figure 2). Note that these structures are markedly different from those of the ABS (figure 1). A peptide, isolated from Conus geographus and designated omega toxin, blocks calcium entry into the nerve terminal during the presynaptic action potential (Kerr and Yoshikami, 1984). Inorganic cations such as Ni2+, Mn2+, and Coz+ can block calcium influx in a competitive manner (Nachshen, 1984; Drapeau and Nachshen, 1984; and see reviews by Hagiwara and Byerly, 1981; Kostyuk, 1981; Edwards, 1982), while the 16 .>ufi>«uoo auccozu azuonnu amuvoa uuzu mucous use: we nousuozuum .m gunman in; 2 :8 ”12.2312 2 2 mzo 2 on: n26 2 on: _ _ _ _ Noz oooonz nxoooo oooom: mum Noz 4_2 mmzezo . £80 0 «zuuzoqmwzew 0 onzo mxoo n20 zo onzo 17 organic cation, methylmercury, blocks calcium influx in an apparently noncompetitive fashion (Atchison gt gt, 1986). Other inorganic cations, La3+ (Nachshen and Blaustein, 1980, 1982) and Cd2+ (Nowycky gt gt, 1985; Narahashi gt gt, 1986) preferentially block some calcium channels. Organic calcium antagonists include verapamil and D-600; however, these antagonists may not be calcium specific but may also affect sodium channels (Van der Kloot and Kita, 1975; Nachshen and Blaustein, 1979). Other calcium antagonists, the 2+ channel dihydropyridines, have been shown to modify Ca activity. For example, nifedipine and nitrendipine act as a calcium antagonists whereas Bay K 8644 acts as a calcium agonist (Hess gt gt, 1984). Calcium channels in neuronal tissue appear to be much less sensitive to verapamil, D-600 and dihydropyridines than are calcium channels in cardiac or vascular smooth muscle (Gotgil'f and Magazanik, 1977; Nachshen and Blaustein, 1979; Daniell gt gt, 1983; Glossman gt gt, 1984). This suggests that there may be differences between calcium channels in excitable membranes of various different tissues. C) Calcium Channel Inactivation Inward calcium currents are found in many cell membranes, and have been shown to relax with time (Standen, 1974; Hencek and Zachar, 1977; Kostyuk and Krishtal, 1977; Tillotson, 1979). In some cases the calcium currents relax 18 with time under a maintained depolarization (Tillotson, 1979; Eckert and Tillotson, 1981; Fox, 1981). Some calcium channels (for example, those in egg cell membrane of Neanthes, and in synaptosomes) have been shown to inactivate in a voltage-dependent manner (Fox, 1981; Nachshen, 1985a; Ashely, 1986). Other calcium channels (for example, neurons of Aplygia californica, rabbit sino-atrial node and calf Purkinje fibers) have been shown to inactivate in a calcium- dependent manner (Tillotson, 1979; Brown gt gt, 1981; Eckert and Tillotson, 1981; Marban and Tsien, 1981). It is also possible that some channels may inactivate in both a calcium- and voltage-dependent manner (possibly synaptosomes, Suszkiw gt gt, 1986). Therefore, flow of inward current through calcium channels in different tissues may be terminated by different mechanisms. Competitive Antagonism -- 5 Possible Mechanism Several lines of evidence suggest that ABS act as competitive antagonists of calcium at a common presynaptic site. ABS with neuromuscular blocking activity tend to be large, often charged molecules which suggests they should act outside the nerve terminal. The effects of some of the ABS occur rapidly, and are rapidly reversed by removing the drug, (Wright and Collier, 1977; Fiekers, 1983a; Prado gt gt, 1978; Tamaki, 1983), which also suggests they act outside the nerve terminal. Twitch tension measurements 19 obtained using the isolated phrenic nerve-diaphragm preparation of rats with bath application of aminoglycosides showed that increasing CaCl2 in the bath caused a parallel shift to the right in the log dose response curve, thus demonstrating competitive antagonism (Prado gt gt, 1978). Two lines of evidence are consistent with a general effect of ABS on calcium-dependent transmitter release. First, neomycin blocks release of norepinephrine and ACh (Wright and Collier, 1977) and streptomycin blocks release of L-glutamate (Washio, 1984), thus the effect of the ABS is not specific for cholinergic neurons. Second, increasing bath calcium has been shown to reverse or partially reverse the neuromuscular block caused by several ABS (Elmqvist and Josefsson, 1962; Pittinger, 1970; Prado gt gt, 1978; Singh gt gt, 1978, 1979, 1982; Fiekers, 1983a; Washio, 1984). Based on these findings coupled with the decrease in 3, caused by aminoglycosides and other ABS, it has been proposed that ABS act as competitive inhibitors of calcium influx. Although the available evidence is consistent with this notion, it is not sufficient to prove that blocking calcium influx is the cause of the neuromuscular block. AB-induced inhibition of calcium influx into the nerve terminal has not been tested directly. Since it has not been determined that the ABS block calcium influx, it is possible to explain the experimental data, showing that an increase in the external calcium concentration ([Ca2+]o) can reverse the AB-induced 20 neuromuscular block, based on functional antagonism. It is possible that the ABS have their effects intracellularly and that increasing the internal calcium concentration relieves the AB-induced effect by noncompetitive functional antagonism. For example agents such as 4-aminopyridine and tetraethylammonium (TEA) which prolong the presynaptic depolarization by blocking K+ efflux (Armstrong and Binstock, 1965; Kusano gt gt, 1967; Yeh gt gt, 1976; Lundh, 1978) and thus increase the internal calcium concentration, can relieve the block of neuromuscular transmission caused by botulinum toxin (Cull-Candy gt gt, 1976; Lundh gt gt, 2+ channels but is 1977). Botulinum toxin does not block Ca believed to affect ACh release by intracellular actions (Wonnacott gt gt, 1978; and see reviews by Narahashi, 1974; Howard and Gundersen, 1980). Moreover, the effects of myasthenia gravis, which is a postjunctionally-directed disease can also be relieved with aminopyridines (Kim and Sanders, 1980; Kim, 1982). Since aminopyridines and TEA cause functional antagonism by increasing the internal calcium concentration they can reverse the neuromuscular block caused by presynaptic intracellular events and/or postjunctional events. Therefore, in order to determine whether increasing [Ca2+]O reverses the AB-induced neuromuscular block by competitive antagonism or by functional antagonism it is necessary to know if ABS block 2+ Ca influx. The goal of this project is to determine directly whether ABS reduce depolarization-induced calcium 21 influx into the nerve terminal. Synaptosomes The small size of the presynaptic motor nerve terminal prohibits use of manipulations (eg, impalement with a recording micropipette, Ca2+ selective microelectrode, or injection of test agent) that would give direct information about calcium influx. Thus, in order to measure calcium influx another system must be used. Gray and Whittaker (1962) developed a procedure for preparing pinched off nerve terminals (synaptosomes) from mammalian brain tissue. Brain tissue is used as the source of synaptosomes, since isolation of nerve terminals from the neuromuscular junction is not feasible due to the small number of nerve terminals compared to the large quantity of muscle. Synaptosomes provide a useful model for studying physiological and biochemical processes which occur at presynaptic nerve terminals (Blaustein, 1975; Blaustein gt gt, 1981). Synaptosomes retain many morphological and functional properties of intact neurons (Blaustein gt gt, 1977). For example, synaptosomes maintain a resting membrane potential that responds to depolarizing agents (Blaustein and Goldring, 1975). Synaptosomes retain a functional choline uptake system (Haga and Noda, 1973), and can synthesize and release ACh (Haga, 1971). Synaptosomes also retain functional glycolytic and oxidative metabolic 22 pathways. Synaptosomes accumulate potassium, extrude sodium (Blaustein gt gt, 1977), regulate Ca2+ influx (Blaustein, 1975; Nachshen and Blaustein, 1980) and release transmitter after a depolarization—induced calcium influx (Blaustein, 1975). Despite these advantages there are several problems associated with the use of synaptosomal preparations (Blaustein gt gt, 1977). First, synaptosomal preparations may not contain only pure nerve terminals, but may also contain other membranes or subcellular organelles such as mitochondria. Second, damaged or nonfunctional nerve terminals may be present. Third, in most cases the terminals obtained from homogenates are heterogeneous with respect to the transmitter they contain. Fourth, and most important, the time resolution of radiolabel flux measurement into synaptosomes is much slower than the time course of synaptic transmission. Normal synaptic transmission is completed in milliseconds (Katz and Miledi, 1965a, 1967), whereas depolarization-evoked influx of Ca2+ into synaptosomes is measured over periods of seconds. Use of specialized rapid mixing techniques allow this measurement period to be shortened and permits a time resolution of 100 msec or less (Nachshen, 1985a; Suszkiw gt gt, 1986). Using these techniques, Nachshen (1985a) reported that results obtained during shorter time intervals corresponded reasonably well to those obtained at 1 sec, and that values obtained with the rapid mixer were similar to 23 values obtained by hand-pipetting at times of 1-10 sec. Calcium Uptake Into Synaptosomes Depolarization leads to an increase in calcium permeability of the prejunctional membrane (Baker gt gt, 1971; Llinas gt gt, 1981a). Since the extraterminal calcium concentration exceeds the intraterminal calcium concentration (Nachshen, 1985b), the increased permeability leads to calcium influx. This calcium influx is the trigger that couples nerve terminal excitation and transmitter release (Katz and Miledi, 1967, 1969). Calcium is known to be the trigger because axonal depolarization in the absence of calcium does not cause transmitter release (Katz and Miledi, 1965b; Miledi and Slater, 1966). The properties of calcium influx into synaptosomes have been studied extensively. Backflux of radioactive calcium is negligible during the first 10 seconds of incubation (Nachshen and Blaustein, 1980), thus the 45 Ca movement measured during this time represents influx, rather than net flux. Two phases of calcium entry into synaptosomes have been demonstrated (Gripenberg gt gt, 1980; Nachshen and Blaustein, 1980; Nachshen, 1985a): a fast phase mediated by a pathway that is inactivated after 1-2 seconds and is 3+ (< 1 uM), and a slow inhibited by low concentrations of La phase, mediated by a pathway that is not inactivated during long-lasting depolarization (1-2 min) and is only blocked by 24 3+ high concentrations of La (> 0.1 mM) (Nachshen and Blaustein, 1980, 1982; Suszkiw and O'Leary, 1983; Nachshen, 1984). Based on the differential sensitivity to La3+, the two phases of calcium entry have been proposed to correspond to two different calcium channels (Nachshen and Blaustein, 1980, 1982), although other interpretations have also been cited (Wang gt gt, 1985; Suszkiw gt gt, 1986). The fast pathway is of primary interest because it is associated with voltage- and calcium-dependent release of dopamine from striatal synaptosomes (Drapeau and Blaustein, 1983), voltage- and calcium-dependent release of substance P from lower brain synaptosomes (Floor, 1983), and voltage- and calcium-dependent release of ACh from forebrain synaptosomes (Suszkiw and O'Leary, 1983). Voltage-dependant norepinephrine release also paralleled Ca2+ 2+ uptake in a synaptosome preparation; both Ca uptake and norepinephrine release have a fast and slow phase (Daniell and Leslie, 1986). The initial rate of dOpamine release is close to the rate of release evoked by nerve stimulation of intact tissue (Drapeau and Blaustein, 1983) and the time course of dopamine release parallels calcium entry through the fast channel (Drapeau and Nachshen, 1984; Leslie gt gt, 1985). As suggested by Nachshen and Blaustein (1980) the slow phase of calcium uptake may be carrier mediated; Wang gt gt (1985) have shown that under certain conditions the slow phase may 2+ be mediated by a membrane potential-sensitive Na+/Ca exchange mechanism. Measurement of potassium-stimulated 25 calcium uptake by synaptosomes using rapid-mixing techniques has shown that the initial rate of calcium influx is faster than previously predicted, but that two phases of calcium influx are still apparent at the times previously tested (Nachshen, 1985a). These results imply that 1 and 10 second incubation times used in manual mixing experiments are useful time points for measure of the two phases of calcium influx. The potassium-stimulated calcium uptake in a variety of preparations does not occur via the sodium channel as it is not blocked by the Na+ channel blocker, tetrodotoxin (TTX) (Baker gt gt, 1973b; Blaustein, 1975; Nachshen and Blaustein, 1980) or by replacement of external sodium with choline (Blaustein, 1975). Both phases of calcium influx are insensitive to TTX (Nachshen and Blaustein, 1980), but can be blocked by Ni2+, Mn2+, Mg2+ and Co2+ in a competitive manner (Nachshen and Blaustein, 1980; Drapeau and Nachshen, 1984). Verapamil and D-600 also block calcium influx into synaptosomes, but with a much lower potency than divalent cations (Nachshen and Blaustein, 1979; Daniell gt gt, 1983). The slow phase of calcium influx into squid axons is not blocked by the K+ channel blocker TEA (Baker gt gt, 1973a). There is a local electric response in squid neurons, in the presence of external TTX and internal TEA, when there is a high external calcium concentration. (Katz and Miledi, 1969). This evidence implied that the calcium does not enter the nerve terminal by either sodium or potassium 26 channels, so a calcium channel was proposed (Baker gt gt, 1973a). As previously described, it is possible that several calcium channels exist. The increase in calcium permeability is depolarization- dependent; this implies that calcium uptake is voltage— dependent. Depolarization is normally caused by an electrical impulse, however potassium may be used to cause a depolarization and thus induce calcium influx (Blaustein, 1975). The potassium-induced change in calcium permeability is not caused by making the synaptosome irreversibly leaky to calcium since prior stimulation in a solution with a high concentration of potassium does not change the rate of calcium uptake in a solution with a low concentration of potassium (Blaustein, 1975). Nor is the potassium-induced increase in calcium permeability due to incorporation of bulk extracellular fluid by pinocytosis since the extracellular markers mannitol or inulin do not accompany the calcium as it is taken up by the synaptosomes (Blaustein, 1975). Experimental Rationale The studies cited herein were designed to clarify the mechanism by which ABs act prejunctionally. In particular I sought to determine whether block of depolarization-induced 2+ Ca influx by ABS could be demonstrated in isolated nerve terminals. The experiments utilized a synaptosome-enriched 27 preparation that was depolarized by potassium to induce influx of calcium. Effects of ABs on calcium influx were studied during both the fast (1 sec) and slow (10 sec) phases, as well as for total influx over 10 sec. Several ABS: clindamycin, neomycin, oxytetracycline, and polymyxin B (one from each of the 4 groups known to block neuromuscular transmission) were tested for their effects on calcium uptake. Previous experiments have not looked at calcium uptake directly; instead they have used measures (ACh release, EPP, MEPP, etc.) that are believed to be related to calcium influx. I determined calcium uptake into synaptosomes directly through the use of radioactive calcium. Based on previous experiments with isolated nerve/muscle preparations it was expected that the aminoglycoside and tetracycline would decrease calcium influx, clindamycin might increase calcium influx and polymyxin B might decrease calcium influx or have no effect. One possible mechanism by which ABS may decrease calcium influx is by competition with calcium for a common binding site. If the decrease in calcium influx was 2+ ] competitive and reversible, then increasing the [Ca 0 should reverse the effects of the AB. Inorder to determine if the ABS act as competitive antagonists to calcium entry, the ability of calcium to reverse AB-induced block of Ca2+ influx ([Ca2+]o = 0.05mM - lmM) was tested. The attempt at reversal was done using either the concentration of AB that caused 50 percent inhibition (ICSO) or, if the maximal 28 percent inhibition was less than 50%, a concentration of AB that caused maximal decrease of influx during the fast phase. METHOD AND MATERIALS Synaptosomes were isolated, and partially purified, from a homogenate of rat forebrain through the use of several steps of centrifugation. The partial purification was performed to isolate synaptosomes and attempt to remove other cellular (brain) contaminants such as mitochondria and axonal membranes. The mitochondria should be removed as they are capable of calcium uptake and thus could confound the measurements of tracer uptake. (However, there are data that imply that potassium-stimulated calcium uptake is probably associated with synaptosomes only and not with other organelles which may contaminate the synaptosome fraction (Blaustein, 1975)). Extra membranes and cellular components must be eliminated to obtain an accurate measurement of the amount of synaptosomal protein to standardize presentation of results. Synaptosomes were prepared from homogenates of rat (Sprague-Dawley, 175-250 grams, male) forebrains, using a modification of the method of Gray and Whittaker (l962)(figure 3). A 10% (weight/volume) homogenate in 0.32 M sucrose was centrifuged at 1,000 x g for 10 min (Sorvall RCZB; Ivan Sorvall Inc., Norwalk, CT.). The supernatant was recentrifuged at 17,500 x g for 20 min (Sorvall). The 29 30 homogenization: 6 strokes x 550 rpm centrifuge: 1,000 x g, 10 min supernate pellet centrifuge: 17,500 x g, 20 min supernate pellet suspend in 6-7 ml 0.32 M sucrose layer on 1.2 M, 0.8 M discontinuous sucrose gradient centrifuge: 61,900 x g, 2 hr collect synaptosomes gbetween 1.2 M and 0.8 M sucrose) wash with buffer centrifuge: 10,000 x g, 10 min supernate pellet suspend in 3 ml buffer homogenize: 6 strokes x 400 rpm warm synaptosomes — 370 C Figure 3. Preparation of synaptosomes. Flow chart shows the method used for preparation of synaptosomes from rat forebrain. 31 resulting pellet was resuspended in 6 - 7 ml 0.32 M sucrose, and layered onto two discontinuous sucrose gradients that were made with 10 m1 of 1.2 M sucrose (bottom) and about 17 ml of 0.8 M sucrose (middle). The sucrose gradient was centrifuged (Beckman L8-55 ultracentrifuge; Beckman Instruments, Palo Alto, CA.) at 61,900 x g for 120 min using a SW-27 rotor. The synaptosome-rich fraction, between the 0.8 M and 1.2 M sucrose layers, was collected by centrifuging at 10,000 x g for 10 min and then suspended in Ca2+-free buffer. After preparation, the synaptosomes were warmed to 370 C, and were always used within 3 hr. Bradford (1975) has shown that synaptosomes remain viable for 3 - 4 hr, after preparation, at 370 C. Uptake of 45 Ca was measured by incubating 50 ul of synaptosomal suspension with 50 ul of "high-K+" ([K+] = 77.5 mM) or "low-K+” ([K+] = 5 mM) solution with tracer. The high-K+ buffer was used to cause a depolarization-induced Ca2+ influx and the low-K+ buffer was used to control for Ca2+ influx under nonstimulated conditions. ABS were added so as to give final concentrations ranging from 1 to 1000 uM. This range is larger than the dose range used 45Ca uptake was terminated by rapidly diluting clinically. the incubation mixture with a quench buffer containing ethylene glycol bis-(beta-aminoethyl ether) N, N, N', N'- tetraacetic acid (EGTA) and N-methylglucamine. EGTA was added to chelate the calcium making it unavailable to the synaptosomes. N—methylglucamine was included in the quench 32 buffer as a large ion that does not enter axonal sodium channels. Hille (1971) showed that sodium channels are impermeant to methylated ions. Because of this, N- methylglucamine prevents further depolarization. The incubation times were 1 sec (timed with a metronome) for the fast channel and 10 sec (timed with a stop watch) for total calcium uptake. Calcium influx during the slow phase was measured by first inactivating the fast channel by pre- depolarizing (10 sec) in high-K+ buffer before the 10 sec incubation. After 45 Ca uptake had been quenched, the reaction mixtures were filtered through 0.45 um Millipore filters (Millipore Corporation, Bedford, MA.). The filters were then washed twice with 5 m1 aliquots of the quench buffer, and then placed in scintillation vials with solubilizer (1% Triton X-100 in 0.5 M HCL, weight/volume) for at least 10 min. Scintillation fluid, Formula 963 (New England Nuclear, Boston, MA) (10 ml) was then added and the sample counted in a liquid scintillation counter (Beckman LS 7000; Beckman Instruments, Fullerton, CA.). The amount of calcium influx was calculated as the difference between calcium uptake in solutions containing high—K+ and low-K+ concentrations. Appropriate blanks were run and their values were used to adjust the results for nonspecific binding of calcium to the filters. The results (calcium influx caused by depolarization) of initial studies used to determine whether the preparation was viable were expressed in terms of counts 33 per minute (cpm) per ug synaptosomal protein (Lowry gt gt, 1951). The results of the subsequent studies using ABS were ’15 moles) expressed as femtomoles (fmoles; 1 fmole = 1 x 10 of calcium influx per ug synaptosomal protein, or as percent of drug-free control. Solutions and Chemicals The buffer used to suspend the synaptosomes contained (mM): NaCl 145, KCl 5, MgCl2 1, d-glucose 10, and N-2-hydroxyethylpiperazine—N'-2-ethanesulfonic acid (HEPES) 10. The high potassium buffer contained (mM): NaCl 72.5, KCl 77.5, MgCl2 1, CaCl2 0.04, d-glucose 10, and HEPES 10. The low potassium buffer contained (mM): NaCl 72.5, KCl 5, choline chloride 72.5, MgCl 1, CaCl 0.04, d-glucose 10, 2 2 and HEPES 10. The quench buffer used to stop the reaction contained (mM): N-methylglucamine 145, KCl 5, MgCl 1, EGTA 2 l, d-glucose 10, and HEPES 10. The solubilizer was 1% Triton X-100 in 0.5 M HCl (weight/volume). The scintillation fluid used was Formula 963 (New England Nuclear, Boston, MA). Sucrose concentrations (for discontinuous sucrose gradient) were 1.2 M, 0.8 M and 0.32 M. All solutions were made with deionized water (Milli-Q) and had an osmolality of 290-320 mOsm as determined by freezing point depression (Micro osmette, Precision Systems, Inc., Natick, MA). The pH of the solutions (except sucrose) was adjusted to 7.4 using glacial 34 acetic acid or NaOH. Drugs tested include clindamycin hydrochloride, neomycin sulfate, oxytetracycline dihydrate and polymyxin B sulfate (Sigma Chemical Co., St. Louis, MO), and lead acetate (J. T. Baker Chemical Co., Phillipsburg, NJ). The radioactive calcium was used in the form of 45 CaCl2 (ICN Pharmaceuticals, Irvine, CA). Statistical Analysis The results of studies of uptake through the fast and slow channel and of total uptake were analyzed using a randomized block analysis of variance (ANOVA). A randomized block ANOVA was performed for each drug and was used to determine if the blocks (different days the experiments were done on) were significantly different (Steel and Torrie, 1980). If the blocks were not significantly different, a completely random ANOVA was used (Steel and Torrie, 1980). In either case if the effects of AB treatment were significant, Dunnett's t-test (Steel and Torrie, 1980) was used to determine which concentrations caused significantly different effects compared to drug-free control. The results of the calcium reversal studies were analyzed using a blocked factorial ANOVA, followed by the least significant difference test (lsd) if significant differences were detected (Steel and Torrie, 1980). The criterion for significance was p t 0.05 for all studies. RESULTS Uptake gtgg2+ into Synaptosomes Initial experiments were designed to test the effects of altering several different parameters of this system (under drug—free conditions) on calcium uptake, in order to assess the viability of the synaptosomal preparation. The dependence of calcium uptake on the duration of potassium-induced depolarization was determined for periods of depolarization between 1 and 60 sec. The results do not extrapolate back to time zero, a result consistent with that of Nachshen and Blaustein (1980). This has been taken as evidence of multiple phases of uptake, a hypothesis which was substantiated in more elaborate studies using rapid quench, automated mixing techniques (Nachshen, 1985a; Suszkiw gt gt, 1986). As shown in figure 4, two apparent phases of uptake can be seen, a fast phase which appears to end by 2 sec followed by a slower phase which does not reach a plateau for at least 60 sec. This compares favorably with the results of others (Nachshen and Blaustein, 1980; Nachshen, 1985a), in which 1 and 10 sec incubations were used to study the fast and slow channels respectively. The dependence of total calcium uptake on protein 35 36 .ouooqaduuu cu ococ acoaauodxo mamcuo a easy mun monao> was .oxoud: no couuaasqum um: o>qm ou azuuuaDOQ smug uo mocmmoud on» cfi oxuuda nu souumcouoouunau no: .25 m. Enqnunuoa 30a uo oucououd on» SE. mu mo oxmumm .omm cc cu A aouu ocqocnu aoamu cowuonsocu uOu Axe n.5h. :ofiummom SawmmmDOQ cum: a sad: pouuuaaomoc mum: ausooOuducam .SOwunuwuoHOro mo cofiumusc :o moEOmOudoc>n couuuo~0doc an manna: an no mococcodoo .v gunmen A Aoom. m2: . 0m 00 O¢ on ON 0. 00 D d d d P P (5 co 6 c': 9?. 9'. ("mom bfl/de) 3>lVldn +8no ('3 V N 37 concentration was also determined. Calcium uptake was measured using incubation mixtures that contained different amounts of synaptosomal protein. The concentration of protein ranged from approximately 100 - 500 ug. In order to be able to compare results from different synaptosomal preparations the data must be expressed per ug of synaptosomal protein. This is only possible if a linear relationship exists between the concentration of protein in the incubation mixture and calcium uptake. As shown in figure 5 the relationship between protein concentration and 2+ Ca uptake was linear over the range tested. During subsequent experiments with ABS the concentration of synaptosomes used was maintained within this range. 2+ Effects of increasing the [Ca 10 on depolarization- dependent Ca2+ uptake were determined (figure 6). The [Ca2+ 45Ca2+ proportional to the total [Ca2+]o. The [Ca2+] ranged from 0.02 to 1.68 mM. Ca2+ uptake increased rapidly 10 was changed in a manner that kept the amount of O as the [Ca2+]o was increased up to 0.42 mM; at this concentration the preparation began to exhibit saturation of depolarization-evoked uptake. In a viable preparation, Ca2+ uptake should increase initially due to the increased concentration driving force, however uptake should eventually saturate. The presence of saturation suggests the membrane is not leaky to calcium. Based on these results, subsequent experiments using ABS were performed 38 .oou o~ uo oswu couuobzocu ca nu“: .ouoouud_uu 2. once acoewsodxo odocmm u no mudzmou ozu one czozm .oxoad: nu couc~25_um um: o>~o Cu EzmmmcDOQ saw: no mocomoua oz» a“ «guys: do Ecuuwcouoauuaao an: .z& m. EsmmmnDOQ zo~ no vacuumed 02D 2‘ no go vacuum ..cuou0ud. uoEOuODroaa uo mcomuuuucoocoo acououu‘csmn oxoud: +~au .26 n.55. cououasqunnsauuucuom .m ou:o_m 3.: 2652.. con oov com com 00.0 P 1 db - q d (ooovde) 3>Wldfl+zDO 39 .002 ad no 05‘» :ouuanaocu so sad: .ouoo«~dquu ca 0200 acoauuodxo ouocuu c Eouu one uoaqn> one .oxoumz no oououasuuo a»: o>uo cu azuunouOQ so“: no mocomoud ozu cu oxnuas «mascuu couoouuazu on: .25 m. EnquunOOQ 30H mo oocomoud can :fi no mo oxmmd: .uco‘uouucoocou ocuauo> an wan .mu 0» no uo owumu msmm may :wmucou nousuxus coquanzucu acououumv one . — no. no 20mw022u a mo .cowu:~om asqmmmuod xa m.nn. moaoa0uQ02>u conquaHOQop an undue: +~mu .m ousmfim 2223 23.0.30 N m... ._ 0.6 00 ”- s (cud bfi/de) 3xv1dn +303 40 with a [Ca2+]o that was equal to 0.05 mM. This concentration was in the rapidly-rising portion of the Ca2+ uptake curve. The effect of lead was determined as a test of our ability to antagonize potassium-stimulated Ca2+ uptake. Lead is known to inhibit calcium uptake into synaptosomes (Nachshen, 1984; Suszkiw gt gt, 1984), and to block transmission at the vertebrate neuromuscular junction (Manalis and Cooper 1973; Atchison and Narahashi, 1984). Total Ca2+ uptake was not altered by lead at concentrations ranging from 0.1 - 10.0 uM. At a concentration of 100 uM lead caused a statistically significant decrease in total calcium uptake (figure 7). This decrease was at a higher concentration than that reported by other investigators (Suszkiw gt gt, 1984). Concentrations of 20 - 100 uM lead have been shown to cause a decrease in nerve-evoked release of ACh at the neuromuscular junction (Atchison and Narahashi, 1984), an effect that can be overcome by increasing extracellular calcium. Based on the above results it appeared that the synaptosomal preparations were viable, were capable of 2+ during depolarization and of having this 2+ taking up Ca effect blocked by a putative Ca channel blocker that also caused neuromuscular block. Subsequent experiments were designed to test the effects of ABS on depolarization- 2+ dependent and -independent Ca uptake. 41 .~0uucoo ooh“ (baud no saga soup accumuuqc >~a2oouuucouu a. o=~c> oz» couaouomu M.~.x”w“wuww :< .002 an an: oa.u :o—aaa=u=_ 02% .mflaouufluwuw” “WHMHOMSMWcow mucosquoaxo a» loan 0 accouoq no can-on no 0a n no uM—nmou ombuuzozu guano 2.29 .coou no occuuuumcmocmu-mmm.unwuuo.MUMWMMWM 622 c. nosoaoudocsn .26 m.-. conqunuonoeuas‘uuauo a x .N :23 o.(V1dn +393 :ON_ 42 2+ Total 9g Uptake The first goal was to determine if the ABS had any effect on total uptake of Ca2+. In subsequent experiments the two phases of Ca2+ uptake were examined separately to determine if ABS blocked one or the other phase preferentially. It should be noted that it is possible for ABS to alter Ca2+ uptake via the fast channel even in the absence of an apparent effect on total uptake. Neither neomycin (n = 7), nor clindamycin (n = 9) had 2+ over the entire any effect on total uptake of Ca concentration ranged tested (1 - 1000 uM). As shown in figure 8, neomycin may cause slight deviations from control but does not cause a statistically significant alteration of depolarization-evoked uptake. As shown in figure 9, clindamycin does not cause any significant deviations from its drug—free control value. Oxytetracycline and polymyxin B each decreased total Ca2+ uptake. The results of seven experiments with oxytetracycline and eight experiments with polymyxin are shown in figures 10 and 11 respectively, and are expressed as percent of drug-free control. Oxytetracycline at concentrations of l - 100 uM caused a slight increase in Ca2+ uptake, but this effect was not statistically significant. The concentration of 500 uM caused a slight 2+ decrease in Ca uptake, but again this effect was not statistically significant. At the highest concentration 43 .cflmuoHQ HmEOmoummcwm ms\mxmums m0 mmHOEm hn.m H va.vh mamsqm Houucoo one .me H Houucoo commumsup mo ucmwwmm mm commmumxw Amumofiamwuu SM weep gummy mucmefluomxm co>wm wo myasmou may m3onw ammum mesh .22: oooa I a. cfioweooc mo mocmmmum map cw mmEOmoummcwm ASE m.nnv possumaomeIEDAmmmuom an ASOMDMQDUSM umm OHS mxcums +~mu Hmuoa .m wusmwm 44 000. 33 op. Adm—.0... m oeamvm Z _o>s_omz o _ d .00 00. -OV. (IOJlU°°°/o) 3)W.Ldn +300 45 .cwmuoum HmEOmoummcwm ms\mxmums mu moHoEw mm.om H mh.wma magnum Houucoo one .zmm H Houucoo mmuwnmsup mo+wcmouom mm commmumxo Amumofiamfluu CM meow nommv mucweflummxo mew: mo muasmmu may msonm nacho mace .225 coca I Hy SMU>E8©cflao wo mocmmmum map SM mmEOmoummcwm ASE m.hhv pmnwumaommpsadwmmmuom Sn Acoflumnsocfl com oav mxmuan +~mu Hmuoa .m musmflm 46 000 _ a mgamwu .23 2.2232. .8 oo. o. 00 1.5.0... .00 _ -0N. (IOJWOO‘Vo) 3>W1dn +200 47 .Houucoo mmHMImsup wo ucsu Eouw ucmummmwo waucmoflmwcmwm mm msam> map mmumowpcfl .20 xmflumumm c4 .cwououm HmEOwoummcwm m5\mxmums m0 mmHOEm mh.m H mv.mm mamsqm Houucoo one .zmm H Houucoo ooHMImsup wo ucmommm mm commoumxm .mumoflamwuu am 0:00 nommv mucmewummxm cm>mm mo muasmmu may mBOcm nmmum mane ..zs oooH I H0 mowaowomuuwu>xo mo mocmmmum gnu cw mmEOmouamcwm .25 m.nhv powwumaomopIEdwmmmuom >2 .coHumnsocfi 0mm ca. mxmumz +mm0 Hmuoe .oa wusofim 48 .2 3 m2 306.222.3158 by 000 _ 00 _ .._<._.0.._. o. erase. 0. .nOO. <5 (0 (IOJIU0°%) 3>Iv1dn +2I01) Io: 49 .Houucoo wmumumzup mo umnu scum ucmquMHU waucmofiwwcmflm ma osam> wnu mmumoflpcfl .20 xmwumumm c4 .cfimuOHQ Hmsomoummcwm md\wxmums m0 mmHOEw hm.m H mm.hm magnum Houucou one .zmm H Houucoo mmHMImsup mo ucmwwmm mm pwmmmumxm .mumoflamwuu aw mcop gummy mucmfiwuwmxm unmflw mo muaswmu may mzonm sauna mane ..29 coca I av cwxwfimaoa mo oocmmwum map cw mmEOmoummcwm .25 m.nnv pmNMHMHommpIESMmmmuom >2 .cofiuwnsocw 0mm 0H0 mxmpms +~mo Hmuoe .HH musmfim 50 000 . 1D .23 00. ...<...0... d ’ ‘ H. wees.e z. x>2>40d 0. 00 .69 10¢. (|°J¥U°°%) ENVIdfl +200 51 2+ (1000 uM) oxytetracycline reduced Ca uptake to 63% of control. Similarly, polymyxin B at low concentrations (1 - 10 uM) caused a small, but statistically insignificant 2+ uptake, and at concentrations of 50 and 100 2+ increase in Ca uM caused a statistically insignificant decrease in Ca uptake. At concentrations of 500 and 1000 uM, polymyxin B caused reductions to 75% and 74% of control respectively, in Ca2+ uptake. Both of these were significantly less than control. Fast Phase gt gg2+ Uptake The fast phase of Ca2+ uptake occurs via a putative calcium channel (Nachshen and Blaustein, 1980), and is thought to be associated with depolarization-induced release of neurotransmitter (Drapeau and Blaustein, 1983; Suszkiw and O'Leary, 1983; Drapeau and Nachshen, 1984; Leslie gt gt, 1985; Daniell and Leslie, 1986). Since the fast phase of Ca2+ uptake is associated with neurotransmitter release it is the phase that is of most interest to the neuromuscular block caused by ABS. 2+ Neomycin (n = 7) caused a decrease in Ca influx via the fast channel (figure 12). Ca2+ uptake was decreased by neomycin over the entire concentration range tested (1 - 1000 uM), however only the results at 500 and 1000 uM were significantly lower than control. These concentrations caused reductions to 66% and 54% of control respectively. 52 .Houucoo wmuwlmsup mo umnu Eouw ucmummwflp haucmowmwcmwm ma msHm> on» mmumowocw .«. xmwumumm ad .cflmuoum HmEOmoummcmm m5\mxmums m0 moaoaw om.H H hm.om magnum Honucoo one .zmm H Houucoo mmuwIm9u© mo ucmwwmm mm commmumxm .mumowamwuu SH 0200 sumo. wucmefluwmxm unmwm mo muanmou on» mBOnm sauna mass ..25 oooa I H. cwomeooc mo mocmmoua may ca moEOmouchwm .28 m.>>. pmuwumHommpIEdwmmmuoa an .SOMDMQDUSH omm H. mxmums +Nm0 mmmnm ummm .NH musmflm 53 000 . N. ee:m.u .23 2.9282 00. o. b 2 T d ...m may moumoHpcw .2. xmwuoumm ca .cflmuoHQ HMEOmouchwm m9\mxmums m0 mmHOEM om.~ H mm.ma mamsum Houucoo one .2mm H Heuucoo onMImsup mo ucmowmm mo pmmmmumxo .muoowamfiuu ca 0200 sumo. muc05wumaxm cm>mm mo muasmmu gnu mzonm namum mass ..2: oooa I H. onwaomomuumumxo mo mocmmoum on“ Ca mmEOmouchwm .25 m.>w. cowaumHoaocIESMmmmuom 2n .cofiumnsocfi com H. oxmums +Nmu ommnm ummm .ma musmwm 55 000. .23 oo. q Fmdfi m. mg:m.u wz 30>0x0 0 _ P 1‘ ....oo_ 0V. (Iouuoo <7.) 3>Iv1dn +2no 54 .Houucoo ooqumsup mo uonu 505m ucouomec wHucooHMHcme mH osHo> ocu mouooHocH .2. meuoumo c2 .cHououm HoEOmoumocew 05\oxoum5 o0 moH05m om.m H wm.mH mHosqo Houucoo one .2mm H Hohucoo ooHMImsup mo ucoowmm mo pommoumxo .ouooHHmHuu SH oSOU sumo. mucoEHuomxo co>om mo muHsmou onu msonm smoum mHne ..2= ooOH I H. ocHHomuouuouexo mo oocomoum osu SH mo50mouaoc>m .25 m.hh. poNHuoHoaopIEDHmmouom 2n .coHuonsoaH Dom H. oxouas +~o0 omonm umom .MH ousmHm 55 m. o2:m.u .23 2 306515208 000. 00. 0. . n u w u u 4 Av nJv nu a ..0m n I m. e V Ha .. Ice 3 n/w .. 0 AU - w :00. m em onu mouooHch .2. wauoumo c2 .cHououQ Ho50moumoc>m ms\oxoums o0 moH05m mo.H H mm.m mHosqo Houucoo one .2mm H Houucoo ooHMImsup mo ucoouom +~mo powmoumxo .ouooHHaHuu 2H oSOG sumo. mucoEHuoaxo uano mo muHsmou onu ozonm smoum mHne ..2s OOOH I H. :Hx>5>Hom mo oocomoum on» cH mo50moumocem .25 m.en. nouHuoHoaooIESHmmouom >2 .aoHuonsocH oom H. oxoum: +mo0 omonm pooh .vH ousmHm 57 s. mess.l .21 . 5.9259. ooo_ oo. , o. d emHunooHMHanm mH osHo> on» mouoqucH .2. meuoumo n2 .cHouoHa Ho50moumoc>m m2\oxoums o0 moH05w mo.m H mm.m~ mHosqo Houunoo one .2mm H Houunoo ooHMImsup mo unoouommmo commouaxo .ouooHHaHuu CH onoo nooo. mucoEHuoaxo och mo muHsmou onu m3onw naonm mHne ..29 oOOH I H. cHo>5o©cHHo mo oonomoum on» 2H mo50moumoc>m .25 m.en. poNHHoHomopIESmeouom en .coHuonsonH oom H. oxoums +mo0 omonm pooh .mH ousmHm 59 .23 on. mH unamwu Z . 0>2W1dn + 200 6O Oxytetracycline (n = 7) caused a statistically I O O 0 + Significant decrease in Ca2 uptake, to 35% of control, at a concentration of 1000 uM. The other concentrations ranging from 5 - 500 uM caused slight, though statistically insignificant decreases. The results of these experiments are shown in figure 13. At concentrations ranging from 1 to 500 uM, polymyxin (n = 8) caused an increase in Ca2+ uptake (figure 14). However, only the results at the 5 uM concentration were significantly different from drug-free control. At 5 uM 2+ uptake via the fast polymyxin caused an 85% increase in Ca phase. Polymyxin did not decrease fast phase Ca2+ uptake at any concentration tested. Similarly, clindamycin (n = 9) does not decrease calcium uptake (figure 15). Rather, clindamycin causes a 2+ very small, yet non-significant, increase in Ca uptake over the entire concentration range tested (1 - 1000 uM). 2+ Slow Phase gt 9g Uptake Neomycin (n = 6) does not cause a significant decrease in slow phase Ca2+ uptake. However, as depicted in figure 16, neomycin causes a slight decrease in slow phase Ca2+ uptake at the highest concentration (1000 uM). Oxytetracycline (n = 6), at concentrations of 500 and 1000 uM, caused a significant decrease, to 70% and 36% of 2+ control respectively, in slow phase Ca uptake (figure 17). 61 .cHououm Ho50moumocmm ms\oxouas o0 moH05m Hm.¢H H oo.Hn mHoon Houucoo one .2mm H Houucoo oouonsup mo ucoouommmo pommoumxo .ouooHHmHuu 2H ocoo nooo. mucoEHuomxo me mo muHsmoH onu m3onm nmoum mHne ..2s oooH I H. nHoesoon mo oocoooum onu 2H mo50moumocem .25 m.en. poNHuoHomopIESHmmouom en .ESHUHoo on .25 m.>h u M .coHuouHuoHomoUoua noumo coHuonsonH oom OH. oxoum: +~o0 omona Bon .oH ousmwm 62 000 . o. on:m.u .23 2.8282 8. 3040 +00. +0.... (IOJWOG %) 3>lV1dn +200 63 .Houucoo ooumImsup mo uonu 5050 ucouoHMHp mHucooHMHanm mH osHo> onu mouooHccH .2. meuoumo n2 .cHououa Ho50moumon>m mo\oxoums o0 moH05m mm.m H om.mm mHoon Houacoo one .2mm H Houucoo ooMMImsup mo ucowwoa mo powwoumxo .ouooHHmHuu CH oc0© nooo. mucoEHuomxo me mo wuHsmou onu m3onm nmoum ane ..25 OOOH I H. ocHHowoouuouexo mo oocomonm onu 2H moEOmoumonem .25 m.>h. poNHuoHomopIESHmmouom en .55H0Hoo on .25 m.>n I x .coHuoNHuoHomopoua woumo noHuonsonH com 0H. oxoum: +No0 owonm 30Hm .nH ousmwm 64 m. ogsm.. .23 uz_._o>o<5u;xo 000. cc. Irrom O (0 +00. (IOJWOG‘Vo) 3XV1dn + 2°C) 65 .Houucoo mwumnmsun wo umnu Eouw ucmummmwn maucmoflwficmflm ma msHm> may mmumowccfl Aav xmflumuwm c4 .cwmuoum anaemoummcmm mn\mxmuas mu mmaosw om.a H mh.mm mamsvm Houucou was .zmm H Houucoo mmum1@5H@ mo unmoumm+mm nwmmmumxm Awumowaawuu :fi meow cummv muamaflummxm HDOM mo muasmmu may mzonm samum maze .Azs coca I H. cfix>5>aom mo mocmmmum may cw mmEOmoummcwm ASE m.nhv kuwumaomwwladfimmmuom an AESMUHMU o: .28 m.hh n M “newumeumHommcmum umumm cofiumnsucfl 0mm oav mxmum: +mmo mmmna 30am .ma wusmwm 66 304m 3.: ma mgamvu z_x>2>._om 00. 1‘ I ”f .00 r.00. (IOJW09 %) BMW. d“ + 303 67 .cwmuoum anaemoummcmm m5\mxmums mo mmaosm Hm.om H hm.moa mamsvm Houucoo mne .zmm + Houucoo mmumnmsuc mo unmoumm mm vmmmmumxm Awumowamfiuu cw meow gummy mucweflumaxm xfim mo muHSmmu may mzonm nmwum mans .Azs oooa I av GMU>EM©CMHU mo wocmmwum may Ga mweomoummcwm ASE m.hhv omuflumaommolfisflmmmuom an “Edwoamo o: .25 m.nn u x “newumeuwaomwomum umumm :oflumnsucfl 0mm oav mxmums +~mu wmmnm 30Hw .mH munmwm 68 a" mg=m*u :23 2.323230 00. 30 ._m WLdT ' Lrow. (IOJWOOVo) 3)! Vldn +z°3 The lower concentrations did not decrease slow phase Ca2+ uptake. 2+ Polymyxin B caused a decrease in total Ca uptake but not in uptake via the fast channel; this would imply that polymyxin affects the slow phase of Ca2+ 2+ uptake. Polymyxin did cause a decrease in Ca uptake via the slow phase over the entire concentration range tested (5 - 1000 uM). The results of four experiments with polymyxin (figure 18) showed a decrease from drug-free control, but the decrease was statistically significant only for concentrations of 100, 500 and 1000 uM. These concentrations caused reductions to 61%, 57% and 44% of control, respectively. Clindamycin which had no effect on either total or fast 2+ channel Ca uptake, also had no effect on the slow phase of calcium uptake (n = 6), as shown in figure 19. The Effects of Antibiotics on Baseline (Low §fl_932+ Uptake Each of the ABs caused a statistically significant 2+ change in Ca uptake under baseline conditions. Neomycin and polymyxin (5 uM) caused a statistically significant I I + increase in Ca2 uptake during 1 sec of incubation, under non-depolarized conditions. Neomycin, oxytetracycline and polymyxin, at high concentrations, each caused a statistically significant decrease in depolarization- 2+ independent Ca uptake during 10 sec of incubation both in the absence and presence of predepolarization. Clindamycin, 70 at high concentrations, caused a statistically significant decrease in baseline Ca2+ uptake following predepolarization. The concentrations of ABs that caused changes in baseline Ca2+ uptake do not correspond exactly with the concentrations of ABs that caused changes in net 2+ uptake. Although baseline Ca2+ uptake was 2+ stimulated Ca changed, the amount of Ca uptake in the absence of stimulation is very small compared to that under K+ -stimulated conditions. Figures 20 - 22 depict the difference in baseline Ca2+ uptake and net stimulated Ca2+ 2+ 2+ uptake, for total Ca uptake, fast and slow phase Ca uptake, respectively. The values depicted are for drug—free control and the drug concentrations that cause a statistically significant difference in baseline Ca2+ uptake as compared to drug-free control. The baseline amounts of Ca2+ uptake is in fact smaller than the standard errors of 2+ the means of the net stimulated Ca uptake. Summary —— Concentration Response Tables 1 and 2 summarize respectively the significant 2 2+ effects of the various ABs on total Ca + uptake, and Ca uptake via the fast and slow phases. Neomycin and 2+ clindamycin had no effect on total Ca uptake, while oxytetracycline (1000 uM) and polymyxin (500 and 1000 uM) both caused a decrease in total uptake of Ca2+. Neomycin (500 and 1000 uM) and oxytetracycline (1000 uM) caused a 71 .cflomemocfiao .quo “m :flxsssaoa .wqom «mcflaomomuumuhxo .Mxo “aflomeow: .omz "How pcmum mcoflumfi>munm one .mxmuoa mu mcwammmn ow wmcmno unmoflMAcmflm madmOAumflumuw m pomswo awn» Azsv codumuucmmmoo mfi comm pom Houucoo mGHMImsup mum omuoflmwo .mmEOmoummcmm oucfl Amnmn pmmfiuumv mxmua: mo Hmuou Ass m.nn u so omumassflumu x um: cam Amman anaemo coflumnsoafi now mm m mcwusp mxmums +wa ASE m u +xv mmwammmo mo c0mwnmeoo d .om musmfim no N mgsa -v m > ._ 0 d o w z o o o _ o on o o _ o z _.._ o W. I Z W W W W / :é;1" ” (6 rt / ED |(> LU J) 3 >1 V J. :1 n +2 D I) 73 .om muzmuu :« an «sun on» mun neoduaw>muno one .mxmums mu mcwawmmn ca omcoco unoOwuucmum u-mo«umfiumum a pounce umnu .25. cOwumuucmmcou mg comm can Houucoo mmuunmsuv mun omuoummn .mmEOuouchxm oucw .mumn confluumv mxmums no mmmzm umnu .m.nh u x. coumaasfiumn x um: can Amman pwaomv :oflumnsocfi 0mm a m mcwuso mxnum: +~mw .28 m u +xv mmwammun mo comaummsoo c .Hm musmfim .240 fl , >40; mm /, o I K) O N 1 O O «3 (W/alown 3>Wldn .203 l fi IO N 75 .om musmflm ch mm mean on» was mcoHuMw>munw one .mxmumo mu mcaammmn cfi mmcmso ucmoflmficmflm aaamofiumflumum m ommsmo umnu AEDV coflumuucmmooo mm comm pow Houucoo wmuwlmsuc mum omuowmma .meomoummcwm oucfl Amumn wmmfiuumv mxmums mu mmmcm 30Hm ASE m.hn u x. owuwasafiuml x am: can Amman pflaow. c0wumnwumaoamomwa mcfisoHHOM coflumnzocfi + omm OH m mcfiumo mxwuaa +Nm0 ASE m u +Mv mafiammmn mo cOmAHmQEOU < .NN wusmfim 76 NN usamrm 2.1.0 *40Q >x0 000.000 0 000. 000 00. 00 0 000. 000 0 11/,” // V/Wmv mm” H” WI/I/I/Il’l WW WWII/”Ml/I/I omz 000. 00m 0 7M”/ WWI _ VII/WWI o o o o o v m o (n (Em/anew» amudn .200 O O 77 decrease in fast phase Ca2+ uptake, while polymyxin (5 uM) caused an increase in fast phase Ca2+ uptake and clindamycin had no effect. Neomycin and clindamycin had no effect on slow phase Ca2+ uptake, while oxytetracycline (500 and 1000 uM) and polymyxin (100, 500 and 1000 uM) caused a decrease in slow phase Ca2+ uptake. Since the control values varied between experiments the control values are listed in Table 3 and Table 4, expressed as fmoles Ca2+/ug synaptosomal protein. Table 3 (total uptake) and Table 4 (fast and slow phase uptake) also list 2+ the amount of Ca uptake at all points that are significantly different from control. These results demonstrate that clindamycin has no effect on Ca2+ uptake into synaptosomes. Neomycin and oxytetracycline, the two ABs that act prejunctionally to cause neuromuscular block, decrease Ca2+ uptake during the fast phase of Ca2+ (the Ca2+ uptake presumably related to release of uptake neurotransmitter). Based on these results the possibility that ABS act prejunctionally to cause neuromuscular block by 2+ decreasing Ca uptake has not been ruled out. Calcium Reversal Since ABs may have actions that block neuromuscular transmission by prejunctional competitive antagonism of Ca2+ entry into the terminal, I tested the hypothesis that increasing the [Ca2+]O could reverse the neuromuscular block 78 T ble 1. Significant effects ofzantibiotics on net K -stimu1ated (77.5 mM) total Ca uptake (10 sec incubation) into synaptosomes. TOTAL, DOSE ANTBIOTIC n (’lochange) (9M) NEOMYCIN 7 No effect OXYTETRACYCLINE 7 ‘37 1000 POLYMYXIN 8 '25 500 ' '26 1006 CLl-NDAMYCIN 9 No effect 79 33.0 oz 0 30:0 oz 0 z_0>240d 000. V0: W 00m 0n: 0 000. no! N m230>0x0 000. mv: .03; oz 0 00m Vn! N z_0>_20mz A23 Aoocozofiov : 22.3 “cocoa—0.x; : 0_.r0_m:Z< mmoo 304m mwoo hm22>..oa ooo. 3.23... o 889...: o o 883...». s m2...o>o-eouwmquum e pomsno bony eoqueuucuoeou as soon uOu usage: use uo=~e> douucou .v wanna .zmm H :M0uoum ms\mxouos .uoBOnOuaecan cue“ «smug: no 82 caused by an AB. The ABs tested were neomycin and oxytetracycline, because they caused a decrease in Ca2+ uptake via the fast channel. The concentration of AB that was used was the one that caused the greatest decrease in Ca2+ influx. Oxytetracycline (1000 uM) did not significantly alter Ca2+ uptake via the fast phase as compared to drug-free 2+ control, with [Ca ]0 ranging from 0.05 - 1.0 mM. Figure 23 shows both the control and oxytetracycline results (n = 5), 2+ expressed as fmoles Ca uptake/ug synaptosomal protein. When the [Ca2+]o was 0.05 mM (the concentration used for the 2+ 2+ fast phase of Ca uptake) oxytetracycline decreased Ca uptake to 39.8 i 7.4 percent of drug-free control. Even though oxytetracycline caused a slight reduction in Ca2+ uptake at all [Ca2+]o the lines are not statistically different. 2+ Neomycin (1000 uM) did not alter Ca uptake via the 2+1 fast phase as compared to drug-free control, with [Ca 0 ranging from 0.05 - 1.0 mM. Figure 24 compares the drug- 2+ free control values with Ca uptake in the presence of neomycin (n = 5), these results are expressed as fmoles Ca2+ uptake/ug synaptosomal protein. When the [Ca2+ 2+ was 10 0.05 mM neomycin decreased Ca uptake to 68.7 i 7.4 percent of drug-free control. 2+ uptake produced by either The decrease in Ca oxytetracycline (1000 uM) or neomycin (1000 uM) was reversed . . 2+ . by rais1ng the [Ca 10. If these ABs cause competitive 83 .ucmummmap hauCMUMMMGmflm uo: mum mmcwa one .HOQE>m on» no nuofl3 may swap umHHmEm mm3 mm on» powwowpcw uoc mum when mm on» cmnz .2mm H :flmuoum HmEOmouch>m ms\mxmums m0 mmaosw mm pmmmmumxm .wumoflaawuu as meow commv muemefiummxm m>flm mo muasmmu+mcu m3onm comma mass ..25 o.H I mo.ov mcoflumuuemocoo Edwoamo accumuxm m50auM> um .Ammaoufiov maouucoo mmuwImpup no Ammumsomv mafiaowomuumumxo z: coca mo wocmmmum on» ca mmEOmoummcmm ASE m.nnv pmuwumHommpIasfimmmuoa >o Acofluwnsocfl own He mxmumo +mmu mmmcm ummm .mm musmfim 84 0.. m8 «.3a.. 3...... 23.0440 mo oo .3 «o o 3 02 n d I... Hv .1 M 3 iVo w m. / .I .n w 85 .ucmummmap aaucmoflmficmwm uoc mum mmcfia one .Hoo8>m may no cupfiz on» once umaamam mmz mm on» pmumowpcw no: mum numb mm may cwcz .zmm H samuoum HMEOmoummcmm ms\mxmums m0 mmHoEw mm pmmmmumxw .mumoflaafluu ca moon comm. mucmsflummxm m>wm wmmmuasmmu mnu mzocm cmmum many ..28 o.H I mo.o. mcofluouucmocoo Esfloamo Hmcumuxm m50wum> um .Ammaouwo. mHouusoo menu Impup uo .mwumsvm. afloweomc so oooa mo mocmmwum may as meOmoummsmm ASE m.hh. omufiumHommpIEswmmmuom ho AcOwumnsocfl com a. mxmumo +mmu omega ummm .om musmfim 86 0.. 7' em m.=o.. 22E. 55.0440 0.0 0.0 v.0 ‘ N0 N o % ‘T o :_ ‘9. o (Eff/mow» :-I>Iv.LcI n .200 87 2+ 2+ antagonism of Ca influx raising the [Ca 2+ 10 should have reversed the AB-induced decrease in Ca influx in a concentration dependent manner. Over the concentration range of [Ca2+ Ca2+ uptake did not appear to be strictly concentration 10 tested, reversal of AB-induced block of dependent. DISCUSSION One of the proposed mechanisms for AB-induced 2+ influx neuromuscular block is competitive antagonism of Ca into the presynaptic nerve terminal. Although many studies have been done in attempts to determine the mechanism by which ABs cause neuromuscular block, none of the experiments have examined calcium influx, directly. Therefore the experiments contained herein were designed to assess this problem. Because of methodological constraints limiting the use of the vertebrate neuromuscular junction, an alternate assay was used. The assay consisted of measuring Ca2+ uptake into synaptosomes in the presence of each of several ABs that cause neuromuscular block. Some of the ABs did 2+ influx in this system. Since some 2+ cause a decrease in Ca of the ABs caused a decrease in Ca influx via the fast phase it is feasible that this decreased calcium uptake can contribute to neuromuscular block. The experiments contained herein used synaptosomes as a model for the neuromuscular junction. Some evidence for the accuracy of synaptosomes as a model for the neuromuscular junction, with respect to presumed calcium channels, was provided by Nachshen and Blaustein (1979). Both synaptosomes and the neuromuscular junction are relatively 88 89 insensitive to the calcium antagonists verapamil and D-600, whereas other tissues are more sensitive to these drugs. Nachshen (1984) demonstrated that a number of polyvalent 2+ uptake into synaptosomes. cations block fast phase Ca These metal cations also block calcium-dependent transmitter release at the neuromuscular junction (Weakly, 1973; Forshaw 1977; Cooper and Manalis, 1983). All of the ABs except clindamycin had the expected 2+ 2+ effects on Ca uptake. Neomycin caused a decrease in Ca uptake via the putative fast channel. This was expected since neomycin in particular and aminoglycosides in general have been reported to exert predominantly prejunctional neuromuscular blocking actions (Elmqvist and Josefsson, 1962; Brazil and Corrado, 1969; Pittinger and Adamson, 1972; Singh et El: 1979, 1982; Farley gt El, 1982; Fiekers, 1983a). Oxytetracycline also caused a decrease in total and 2+ fast phase Ca uptake. This decrease is in agreement with some of the proposed mechanisms of action for oxytetracycline (Singh et El: 1982). Polymyxin B caused a 2+ 2+ influx via the 2+ decrease in total Ca uptake and in Ca slow phase. In addition to the decrease in Ca influx, low concentrations of polymyxin (5 uM) caused an increase in 2+ fast phase Ca influx. Polymyxin is thought to cause neuromuscular block predominately by postjunctional actions (Singh gt El, 1979, 1982; Fiekers, 1981), thus it was not 2+ expected to cause a decrease in Ca influx. Although clindamycin has been shown to have prejunctional effects 90 (Rubbo gt gt, 1977; Fiekers gt gt, 1983), it did not cause 2+ influx. The fast phase of Ca2+ uptake any change in Ca appears to be associated with neurotransmitter release (Drapeau and Blaustein, 1983; Suszkiw and O'Leary, 1983; Daniell and Leslie, 1986), thus it would be the component of 2+ influx was the mechanism of AB- concern if decreased Ca induced neuromuscular block. From these results it can be seen that neomycin, which causes neuromuscular block by predominantly prejunctional actions, and oxytetracycline, whose mechanism of neuromuscular block is unknown, decrease 2+ Ca influx during 1 sec of depolarization, whereas ABs (polymyxin and clindamycin) that produce neuromuscular block by predominantly postjunctional actions or for which Ca2+ does not provide effective reversal (Singh gt gt, 1982) do not decrease fast phase of Ca2+ uptake into synaptosomes. Clindamycin did not have the predicted effect on calcium uptake; this may be due to the disparate nature of the data upon which the prediction was based. Rubbo gt gt (1977) and Singh gt gt (1982) have reported that clindamycin leads to an increase in spontaneous MEPP frequency and an increase in ACh release. Based on those results it was expected that clindamycin would cause an increase in Ca2+ uptake. However, Fiekers gt gt (1983) have shown that clindamycin altered EPC amplitude, increased EPC decay rate and decreased EPC quantal content. If the decrease in EPC quantal content is due to a decrease in the number of quanta released and not a decrease in the size of the quanta 91 released, then this would be consistent with the fact that 2+ clindamycin did not cause an increase in Ca uptake into synaptosomes. Clindamycin did not alter Ca2+ uptake via the fast phase as would be expected (based on some results). This could have occurred if there is not a general mechanism for all ABs, but if more than one mechanism of prejunctional block exists. For example, neomycin and oxytetracycline 2+ influx while could block by competitive antagonism of Ca clindamycin might have some other prejunctional effect. In order to determine if there is more than one mechanism of prejunctional block, other ABs that are known to block neuromuscular transmission by a prejunctional mechanism will have to be tested. Polymyxin caused paradoxical apparent increase in fast phase Ca2+ uptake. Polymyxin has both pre— and post- junctional neuromuscular blocking actions (Singh gt gt, 1982) with the postjunctional actions predominating (Singh gt gt, 1979; Fiekers, 1981). Polymyxin-induced neuromuscular block is poorly reversed by calcium (Singh gt gt, 1978). Even though synaptic transmission is dependent on Ca2+ (Katz and Miledi, 1965b, 1967, 1969; Dodge and Rahamimoff, 1966; Miledi and Slater, 1966) it has been demonstrated that high levels of ionized calcium in the presynaptic terminal can act to block synaptic transmission (Miledi and Slater, 1966; Kusano, 1970; Adams gt gt, 1985). Perhaps an increase in the intracellular calcium concentration may contribute to neuromuscular block produced 92 by polymyxin. The two ABS (oxytetracycline and neomycin) that decreased fast phase Ca2+ Ca2+ uptake when the incubation was carried out in a 2+ uptake did not alter fast phase solution containing a [Ca 10 ranging from 0.05 - 1.0 mM. Therefore the AB-induced block of Ca2+ uptake can be reversed. However this reversal did not appear to be concentration dependent over the range of concentrations tested. Perhaps lower [Ca2+]o are needed to demonstrate a strict concentration-dependent competitive antagonism of Ca2+. My results are comparable to the recent results of Yoshii gt gt (1986) in which they demonstrated that streptomycin (an aminoglycoside) can block Ba2+-induced 2+ channels into neuroblastoma NlE-llS currents through Ca cells and that increasing the external Ba2+ concentration overcame the AB-induced block of Ba2+ currents. One problem with the results of the experiments contained herein is that the amount of Ca2+ uptake is about 33 - 35% of that obtained by others (Blaustein gt gt, 1977; Nachshen and Blaustein, 1980; Nachshen, 1984, l985a,b; Leslie gt gt, 1983). This may be due to the fact that the other authors used different methods of synaptosome preparation, either the method of Hajos (1975) or the modification of Hajos's method by Krueger gt gt (1979). These other methods for preparing synaptosomes are reported 2+ to produce a purer synaptosomal fraction. Since the Ca uptake results are expressed per ug of protein (the 93 assumption being all of the protein is synaptosomal) a purer preparation would give greater uptake values. The physiological correlate for the Slow phase of Ca2+ uptake is unknown. The Slow phase of Ca2+ uptake may be associated with a channel (Nachshen and Blaustein, 1980) or Na+/Ca2+ exchange (Wang gt gt, 1985; Suszkiw gt gt, 1986). Sheu gt gt (1986) have demonstrated, using rat ventricular 2+ myocytes, that both voltage-sensitive Ca channels and voltage-sensitive Na+/Ca2+ exchange contribute to the increase in the internal calcium concentration during membrane depolarization. If the slow phase of calcium uptake into synaptosomes is due to Na+/Ca2+ exchange then there could be ion movements that would alter the membrane potential (an electrogenic pump). It is also possible that calcium flowing down its concentration gradient could provide energy to pump Na+ against its concentration gradient. The intracellular calcium concentration is buffered by calcium binding or sequestration in mitochondria and other organelles (Lehninger, 1970; Alnaes and Rahamimoff, 1975; Blaustein gt gt, 1977; Kendrick gt gt, 1977; Scott gt gt, 1980). The internal calcium concentration is very low 104 t 8 nM (based on experiments with quin-2, a Ca2+ specific fluorescent indicator) while the external calcium concentration is 1.2 mM (Richards gt gt, 1984). Depolarization causes a 2-fold increase in the internal calcium concentration (Richards gt gt, 1984). Thus the 94 internal calcium concentration remains well below the external calcium concentration. Calcium entry into synaptosomes is dependent on the ratio of the internal and external Na+ concentrations (Coutinho gt gt, 1984; Nikezie and Metlas, 1985). Either increasing the internal Na+ concentration or decreasing the external Na+ concentration leads to greater Ca2+ 2+ uptake. The slow phase of Ca uptake may be included in the mechanism by which the nerve terminal removes Na+ that has entered during depolarization. Therefore the decrease in slow phase Ca2+ uptake probably does not contribute directly to the neuromuscular blocking actions of the ABS. A wide range of concentrations for the ABs was used for the Ca2+ uptake experiments, yet in order to observe a decrease in Ca2+ influx high concentrations of the ABS were needed. The concentrations of ABS needed to cause a C + decrease in Ca2 influx are considerably higher than the normal peak plasma levels of these ABS given clinically (neomycin, polymyxin and oxytetracycline < 10 uM; clindamycin < 40 uM). However, neuromuscular block usually does not occur at these plasma levels unless other agents are present (eg, general anesthetic or neuromuscular blockers) that compromise neuromuscular function. AB- induced neuromuscular block can also occur in patients with hepatic or renal dysfunction that cause an increase in the concentration of AB in the plasma. The concentrations of ABS needed to cause a decrease in 95 Ca2+ influx are generally higher than those needed to cause neuromuscular block in isolated nerve-muscle preparations. Depending on what effect is measured, different concentrations of the ABS are needed to cause a Significant effect on transmission. These effects occur at the following concentration ranges: neomycin 1-600 uM (Wright and Collier, 1977; Fiekers, l983a), polymyxin 2 uM (Durant and Lambert, 1981), clindamycin 200-800 uM (Wright and Collier, 1976a; Fiekers gt gt, 1983), oxytetracycline 2,000- 10,000 uM for Z 80% reduction (Singh gt gt, 1978, 1982). Thus the concentrations needed in synaptosomes are often, but not always higher than those needed in other systems. Several reasons could explain why higher concentrations are needed to see an effect in synaptosomes as compared to the isolated neuromuscular junction. First, synaptosomes are heterogeneous with respect to transmitter; this means that if the effects of ABS that cause neuromuscular block are specific for cholinergic nerve terminals (such as those found at the neuromuscular junction), the effects of the ABS may be obscured. For example the ABS might act only at 2+ channels. As described earlier there 2+ certain types of Ca are multiple types of Ca channels. If, as hypothesized by Yu and Nelson (1986), neurons that utilize different types of neurotransmitters have different Ca2+ channels, the ABS may not act the same at all types of neurons (eg. the ABS may have different affinities for or efficacy at different 2+ types of Ca channels). Second, synaptosome preparations 96 are not pure nerve terminals; they contain free mitochondria, membrane fragments and other cellular debris. 2+ The mitochondria can also take up Ca and thus confound the 2+ results. The Ca uptake in these experiments was measured based on the amount of 45 2+ Ca trapped by the filter. This that entered mitochondria was also 2+ means that any Ca included in the measurement of Ca influx. This problem was reduced by partial purification of the synaptosomes to remove mitochondria. Also the change in potassium . , . + concentration that caused an increase in Ca2 2+ uptake into the synaptosomes, does not alter Ca uptake into mitochondria (Blaustein, 1975), so the experimental design 2+ Should eliminate mitochondrial Ca uptake as a potential variable from the final results (net stimulated Ca2+ uptake). Third, synaptosomes may not represent an accurate model of the neuromuscular junction. For example, different tissues have different types of Ca2+ channels, as shown by differences in the effects of verapamil, D-600 and dihydropyridines (Gotgil'f and Magazanik, 1977; Nachshen and Blaustein, 1979; Daniell gt gt, 1983; Glossman gt gt, 1984), thus synaptosomes may not have the same type of calcium channel as do the presynaptic motor nerve terminals. Even though evidence has been presented that shows synaptosomes and the neuromuscular junction respond the same way in the presence of organic calcium antagonists and multivalent cations (Nachshen and Blaustein, 1979; Nachshen, 1984), this does not mean that synaptosomes and the neuromuscular 97 junction will necessarily respond the same way in the presence of antibiotics. Fourth and finally, block of Ca2+ uptake may not be the only mechanism by which ABS cause 2+ influx neuromuscular block. Competitive antagonism of Ca may be one of many factors involved in neuromuscular block, or it may not be involved at all. If ABS cause 2+ neuromuscular block by blocking the Ca channel, it is not necessary that the ABS act as competitive inhibitors of Ca2+. Also because of the multiple steps involved in synaptic transmission the ABS may also act at a step(s) other than Ca2+ influx to cause neuromuscular block. Some experiments could be done in order to address some of these problems. The first problem could be avoided if the studies were repeated with a pure cholinergic preparation, such as the electric organ of Torpedo. If cholinergic synaptosomes could be used this would more closely resemble the neuromuscular junction than the transmitter—heterogenous synaptosomes which characterize those derived from the forebrain. The second problem can be addressed by using methods that isolate a synaptosome fraction of higher purity (Hajos, 1975; Krueger gt gt, 1979). The problem of determining if the calcium channels of the two tissues are identical is unavoidable, until more is known about the calcium channels of the respective preparations. The fourth issue could be addressed by testing ABS that do not cause neuromuscular block. If those ABS decrease Ca2+ influx then decreasing Ca2+ influx may not 98 cause neuromuscular block. Some Ca2+ channel blockers may Show preferential 2* channels. Nachshen (1985a) has 2 binding to inactivated Ca demonstrated that inhibition of K+-stimulated Ca Ni2+, La3+ + uptake by and verapamil was enhanced in synaptosomes that were pre-depolarized for brief intervals in the presence of Ca2+ channel blockers. Pre—depolarization Should cause Ca2+ channel inactivation in synaptosomes as the inactivation is voltage, and not Ca2+-dependent (Nachshen, 1985a). This implies that some Ca2+ channel blockers may bind preferentially to inactivated Ca2+ channels. This possibility should also be tested for ABS, since this could help explain why ABS that cause neuromuscular block had no 2+ effect on Ca uptake into synaptosomes. Synaptosomes should be depolarized in the presence of an AB before Ca2+ influx is measured. Experiments should also be done in which the synaptosomes are pre-incubated with the ABS, in case the ABS have their effect by inhibiting activation 2+ channel. Pre-incubation with ABS (Opening) of the Ca would resemble physiological conditions more closely than the conditions of the experiments contained herein. If the ABS had their effect by inhibiting opening of the Ca2+ 2+ channel the channel or by binding to the inactivated Ca effects would not be seen in the experiments contained herein. The results described herein do not disprove the idea that ABS can cause neuromuscular block by block of 99 depolarization-induced Ca2+ entry, but rather provide evidence which though weak, is at least consistent with the idea that some ABS may cause prejunctional neuromuscular block by decreasing Ca2+ uptake. Further study, especially with regards to the fast phase of Ca2+ uptake, is necessary to elucidate the mechanism(s) by which ABS cause neuromuscular block. LIST OF REFERENCES LIST OF REFERENCES Adams, D. J., K. Takeda and J. A. Umbach. Inhibitors of calcium buffering depress evoked transmitter release at the giant synapse. J. Physiol. (Lond.) 369: 145— 159, 1985. Alnaes, E., and R. Rahamimoff. On the role of mitochondria in transmitter release from motor nerve terminals. J. Physiol. (Lond.) 248: 285-306, 1975. Anglister, L., A. Shahar, I. C. Farber and A. Grinvald. Growth cones expand tg vit by depolarization under conditions which permit Ca entry. Soc. Neurosci. Abst. 7: 548, 1981. Armstrong, C. M., and L. Binstock. Anomalous rectification in the squid giant axon injected with tetraethylammonium chloride. J. Gen. Physiol. 48: 859-872, 1965. Armstrong, C. M., and D. R. Matteson. Two distinct populations of calcium channels in a clonal line of pituitary cells. Sci. 227: 65-67, 1985. Ashely, R. H. External calcium, intrasynaptosomal free calcium and neurotransmitter release. Biochim. Biophys. Acta. 854: 207-212, 1986. Atchison, W. D., U. Joshi and J. E. Thornburg. Irreversible suppression of calcium entry into nerve terminals by methylmercury. J. Pharm. Exp. Ther. 238: 618-624, 1986. Atchison, W. D., and T. Narahashi. Mechanism of action of lead on neuromuscular junctions. Neurotoxicology 5: 267-282, 1984. Baker, P. F., A. L. Hodgkin and E. B. Ridgway. Depolarization and calcium entry in squid giant axons. J. Physiol. (Lond.) 218: 709-755, 1971. Baker, P. F., H. Meves and E. B. Ridgway. Effects of manganese and other agents on the calcium uptake that follows depolarization of squid axons. J. Physiol. (Lond.) 231: 511-526, 1973a. 100 101 Baker, P. F., H. Meves and E. B. Ridgway. Calcium entry in response to maintained depolarization of squid axons. J. Physiol. (Lond.) 231: 527-548, 1973b. Barrett, E. F., and J. N. Barrett. Separation of two voltage sensitive potassium currents, and demonstration of a tetrodotoxin-resistant calcium current in frog motoneurones. J. Physiol. (Lond.) 255: 737-774, 1976. Becker, L. D., and R. D. Miller. Clindamycin enhances a nondepolarizing neuromuscular blockade. Anesthesiology 45: 84-87, 1976. Blaustein, M. P. Effects of potassium, veratridine, and scorpion venom on calcium accumulation and transmitter release by nerve terminals in vitro. J. Physiol. (Lond.) 247: 617-655, 1975. Blaustein, M. P., and J. M. Goldring. Membrane potentials in pinched-off presynaptic nerve terminals monitored with a fluorescent probe: Evidence that synaptosomes have potassium diffusion potentials. J. Physiol. (Lond.) 247: 589-615, 1975. Blaustein, M. P., N. C. Kendrick, R. C. Fried and R. W. Ratzlaff. Calcium metabolism at the mammalian presynaptic nerve terminal: Lessons from the synaptosome. Soc. Neurosci. Symp. 2: 172-194, 1977. Blaustein, M. P., D. A. Nachshen and P. Drapeau. Excitation-secretion coupling: The role of calcium. In Chemical Neurotransmission 1; years. (eds) L. Stgarne, P. Hedqvist, H. Lagerantz and A. Wennmalm. Academic press. 1981. Bowen, J. M., and W. C. Mc Mullan. Influence of induced hypermagnesemia and hypocalcemia on neuromuscular blocking property of oxytetracycline in the horse. Am. J. Vet. Res. 36: 1025-1028, 1975. Bradford, H. F. Isolated nerve terminals as an in vitro preparation for the study of dynamic aspects of transmitter metabolism and release. In Handbook gt Psychopharmacology. (eds) L. L. Iverson, S.D. Iverson, and S. H. Snyder. Plenum Press, NY, Vol. 1, pp 191-252. 1975. Brazil, 0. V., and A. P. Corrado. The curariform action of streptomycin. J. Pharm. Exp. Ther. 120: 452-459, 1969. 101 Baker, P. F., H. Meves and E. B. Ridgway. Calcium entry in response to maintained depolarization of squid axons. J. Physiol. (Lond.) 231: 527-548, 1973b. Barrett, E. F., and J. N. Barrett. Separation of two voltage sensitive potassium currents, and demonstration of a tetrodotoxin-resistant calcium current in frog motoneurones. J. Physiol. (Lond.) 255: 737-774, 1976. Becker, L. D., and R. D. Miller. Clindamycin enhances a nondepolarizing neuromuscular blockade. Anesthesiology 45: 84-87, 1976. Blaustein, M. P. Effects of potassium, veratridine, and scorpion venom on calcium accumulation and transmitter release by nerve terminals in vitro. J. Physiol. (Lond.) 247: 617-655, 1975. Blaustein, M. P., and J. M. Goldring. Membrane potentials in pinched-off presynaptic nerve terminals monitored with a fluorescent probe: Evidence that synaptosomes have potassium diffusion potentials. J. Physiol. (Lond.) 247: 589-615, 1975. Blaustein, M. P., N. C. Kendrick, R. C. Fried and R. W. Ratzlaff. Calcium metabolism at the mammalian presynaptic nerve terminal: Lessons from the synaptosome. Soc. Neurosci. Symp. 2: 172-194, 1977. Blaustein, M. P., D. A. Nachshen and P. Drapeau. Excitation-secretion coupling: The role of calcium. In Chemical Neurotransmission 1; years. (eds) L. Stgarne, P. Hedqvist, H. Lagerantz and A. Wennmalm. Academic press. 1981. Bowen, J. M., and W. C. Mc Mullan. Influence of induced hypermagnesemia and hypocalcemia on neuromuscular blocking property of oxytetracycline in the horse. Am. J. Vet. Res. 36: 1025-1028, 1975. Bradford, H. F. Isolated nerve terminals as an in vitro preparation for the study of dynamic aspects of transmitter metabolism and release. In Handbook gt Psychopharmacology. (eds) L. L. Iverson, S.D. Iverson, and S. H. Snyder. Plenum Press, NY, Vol. 1, pp 191-252. 1975. Brazil, 0. V., and A. P. Corrado. The curariform action of streptomycin. J. Pharm. Exp. Ther. 120: 452-459, 1969. 102 Brown, H., J. Kimura and S. Noble. Calcium entry dependent inactivation of the slow inward current in the rabbit sino-atrial node. J. Physiol. (Lond.) 320: llP, 1981. Brown, R. D., and P. Taylor. The influence of antibiotics on agonist occupation and functional states of the nicotinic acetylcholine receptor. Molec. Pharm. 23: 8-16, 1983. Caputy, A. J., Y. I. Kim and D. B. Sanders. The neuromuscular blocking effects of therapeutic concentrations of various antibiotics on normal rat skeletal muscle: A quantitative comparison. J. Pharm. Exp. Ther. 217: 369-378, 1981. Collier, B. Biochemistry and physiology of cholinergic transmission. In Handbook gt Physiology: The Nervous System. (eds) J. M. Brookhart, V. B. Mountcastle, E. R. Kandel and S. R. Geiger. American Physiology Society, Bethesda, MD, vol. 1, pp 463-492, 1977. Collier, B., and F. C. MacIntosh. The source of choline for acetylcholine synthesis in a sympathetic ganglion. Can. J. Physiol. Pharm. 47: 127-135, 1969. Cooper, G. P., and R. S. Manalis. Influence of heavy metals on synaptic transmission: A review. Neuro. Tox. 4: 69-84, 1983. Coutinho, O. P., C. A. M. Carval o and A. P. Carvalho. Catci +uptake related to K -depolarization and Na /Ca exchange in sheep brain synaptosomes. Brain Res. 290: 261-271, 1984. Cull-Candy, S. G., H. Lundh and S. Thesleff. Effects of botulinum toxin on neuromuscular transmission in the rat. J. Physiol. (Lond.) 260: 177-203, 1976. Currier, S. P., and H. G. Mautner. On the mechanism of action of choline acetyltransferase. Proc. Natl. Acad. Sci. 71: 3355-3358, 1974. Daniell, L. C., E. M. Barr and S. W. Leslie. 45Ca2+ uptake into rat whole brain synaptosomes unaltered by dihydropyridine calcium antagonists. J. Neurochem. 41: 1455-1459, 1983. Daniell, L. C., and S. W. Leslie. Correlation of rates of calcium entry and release of endogenous norepinephrine in rat brain region synaptosomes. J. Neurochem. 46: 249-256, 1986. 103 Dauterman, W. C., and K. N. Mehrotra. The N-alkyl group specificity of choline acetylase from rat brain. J. Neurochem. 10: 113-117, 1963. Del Castillo, J., and B. Katz. Quantal components of the end-plate potential. J. Physiol. (Lond.) 124: 560- 573, 1954. De Robertis, E. D. P., and H. S. Bennett. Some features of the submicroscopic morphology of synapses in frog and earthworm. J. Biophysic. Biochem. Cytol. 1: 47-56, 1955. Diamond, I., and E. P. Kennedy. Carrier mediated transport of choline into synaptic nerve endings. J. Biol. Chem. 244: 3258-3263, 1969. Dodge, F. A., Jr. and R. Rahamimoff. Co-operative action of the neuromuscular junction. J. Physiol. (Lond.) 193: 419-432, 1967. Drapeau, P., and M. P. Blaustein. Initial release of 3H dopamine from rat striatal synaptosomes: correlation with calcium entry. J. Neurosci. 3: 703-713, 1983. Drapeau, P., and D. A. Nachshen. Manganese fluxes and manganese-dependent neurotransmitter release in presynaptic nerve endings isolated from rat brain. J. Physiol. (Lond.) 348: 493-510, 1984. Durant, N. N., and J. J. Lambert. The action of polymyxin B at the frog neuromuscular junction. Br. J. Pharm. 72: 41-47, 1981. Eckert, R., and D. L. Tillotson. Calcium-mediated inactivation of the calcium conductance in caesium- 1oaded giant neurons of aplysia californica. J. Physiol. (Lond.) 314: 265-280, 1981. Edwards, C. The selectivity of ion channels in nerve and muscle. Neurosci. 7: 1335-1366, 1982. Elmqvist, D., and J. -O. Josefsson. The nature of the neuromuscular block produced by neomycine. Acta. Physiol. Scand. 54: 105-110, 1962. Farley, J. M., C. H. Wu and T. Narahashi. Mechanism of neuromuscular block by streptomycin: A voltage clamp analysis. J. Pharm. Exp. Ther. 222: 488-493, 1982. Fiekers, J. F. Neuromuscular block produced by polymyxin B: Interaction with end-plate channels. Eur. J. Pharm. 70: 77-81, 1981. 104 Fiekers, J. F. Effects of the aminoglycoside antibiotics, streptomycin and neomycin, on neuromuscular transmission. I. Presynaptic considerations. J. Pharm. Exp. Ther. 225: 487-495, 1983a. Fiekers, J. F. Effects of the aminoglycoside antibiotics, streptomycin and neomycin, on neuromuscular transmission. II. Postsynaptic considerations. J. Pharm. Exp. Ther. 225: 496-502, 1983b. Fiekers, J. F., F. Henderson, I. G. Marshall and R. L. Parsons. Comparative effects of clindamycin and lincomycin an end-plate currents and quantal content at the neuromuscular junction. J. Pharm. Exp. Ther. 227: 308-315, 1983. Fiekers, J. F., I. G. Marshall and R. L. Parsons. Clindamycin and lincomycin alter miniature endplate current decay. Nature 281: 680-682, 1979. Fishman, M. C., and I. Spector. Potassium current suppression by quinidine reveals additional calcium currents in neuroblastoma cells. Proc. Natl. Acad. Sci. 78: 5245-5249, 1981. Floor, E. Substance P release from K+-depolarized rat brain synaptosomes at one-second resolution. Brain Res. 279: 321-324, 1983. Fogdall, R. P., and R. D. Miller. Prolongation of a pancuronium-induced neuromuscular blockade by clindamycin. Anesthesiology 41: 407-408, 1974. Forshaw, P. J. The inhibitory effect of cadmium on neuromuscular transmission in the rat. Eur. J. Pharm. 42: 371-377, 1977. Fox, A. P. Voltage-dependent inactivation of a calcium channel. Proc. Natl. Acad. Sci. 78: 953-956, 1981. Fox, A. P., and S. Kranse. Two calcium currents in egg cells. Biophys. J. 33: 145a, 1981. Gilman, A. G., L. S. Goodman, T. W. Rall and F Murad. The Pharmacological Basis gt Thergpeutics, seventh edition. MacMillan Publishing Co., New York. 1985. Glossman, H., D. R. Ferry, A. G011 and M. Rombusch. Molecular pharmacology of the calcium channel: Evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [ 25Iliodipine. J. Cardiovas. Pharm. 6: 608- 621, 1984. 105 Gotgil'f, I. M. and L. G. Magazanik. Effect of substances blocking calcium channels (verapamil, D-600, manganese ions) on transmitter release from motor nerve endings in frog muscle. Neirofiziologiya 9: 415-422, 1977. Gray, E. G., and V. P. Whittaker. The isolation of nerve endings from brain: An electron-microscopic study of cell fragments derived by homogenization and centrifugation. J. Anat. (Lond.) 96: 79-88, 1962. Gripenberg J., E. Heinonen and S.-E. Jansson. Uptake of radiocalcium by nerve endings isolated from rat brain: Kinetic studies. Br. J. Pharm. 71: 265-271, 1980. Haga, T. Synthesis and release of [14C1acety1choline in synaptosomes. J. Neurochem. 18: 781-798, 1971. Haga, T., and H. Noda. Choline uptake systems of rat brain synaptosomes. Biochim. Biophys. Acta. 291: 564-575, 1973. Hagiwara, S., and L. Byerly. Calcium channel. Ann. Rev. Neurosci. 4: 69-125, 1981. Hagiwara, S., S. Ozawa and 0. Sand. Voltage clamp analysis of two inward current mechanisms in the egg cell membrane of a starfish. J. Gen. Physiol. 65: 617-644, 1975. Hajos, F. An improved method for the preparation of synaptosomal fractions in high purity. Brain Res. 93: 485-489, 1975. Hash, J. H. Antibiotic mechanisms. Ann. Rev. Pharm. 12: 35-56, 1972. Hencek, M., and J. Zachar. Calcium currents and conductances in the muscle of the crayfish. J. Hess, P., J. B. Lansman and R. W. Tsien. Different modes of Ca channel gating behavior favored by Dihydropyridine Ca agonists and antagonists. Nature 311: 538-544, 1984. Heuser, J. E. Synaptic vesicle exocytosis revealed in quick-frozen frog neuromuscular junction treated with 4-amino-pyridine and given a Single electrical shock. Soc. Neurosci. Symp. 2: 215-239, 1977. 106 Heuser, J. E., T. S. Reese, M. J. Dennis, Y. Jan, L. Jan and L. Evans. Synaptic vesicle exocytosis captured by quick freezing and correlated with quantal transmitter release. J. Cell. Biol. 81: 275-300, 1979. Heuser, J. E., T. S. Reese and D. M. D. Landis. Functional changes in frog neuromuscular junctions studied with freeze-fracture. J. Neurocyt. 3: 109-131, 1974. Hille, B. The permeability of the sodium channel to organic cations in myelinated nerve. J. Gen. Physiol. 58: 599-619, 1971. Howard, B. D., and C. B. Gundersen, Jr. Effects and mechanisms of polypeptide neurotoxins that act presynaptically. Ann. Rev. Pharm. Tox. 20: 307-336, 1980. Katz, B., and R. Miledi. The measurement of synaptic delay, and the time course of acetylcholine release at the neuromuscular junction. Proc. R. Soc. Lond. (Biol.) 161: 483-495, 1965a. Katz, B., and R. Miledi. The effect of calcium on acetylcholine release from motor nerve terminals. Proc. R. Soc. Lond. (Biol.) 161: 496-503, 1965b. Katz, B., and R. Miledi. A study of synaptic transmission in the absence of nerve impulses. J. Physiol. (Lond.) 192: 407-436, 1967. Katz, B., and R. Miledi. Tetrodotoxin-resistant electrical activity in presynaptic terminals. J. Physiol. (Lond.) 203: 459-487, 1969. Katz, B., and R. Miledi. The statistical nature of the acetylcholine potential and its molecular components. J. Physiol. (Lond.) 224: 665-699, 1972. Kendrick, N. C., M. P. Blaustein, R. C. Fried and R. W. Ratzlaff. ATP-dependent calcium storage in presynaptic nerve terminals. Nature 265: 246-248, 1977. Kerr, L. M., and D. Yoshikami. A venom peptide with a novel presynaptic blocking action. Nature 308: 282- 284, 1984. Kim, Y. I. Neuromuscular transmission in myasthenia gravis. Sem. Neurol. 2: 199-220, 1982. 107 Kim, Y. I., and D. B. Sanders. Further electrophysiological studies of neuromuscular transmission in an animal model of myasthenia gravis. Exp. Neurol. 73: 1-19, 1981. Kostyuk, P. G. Calcium channels in the neuronal membrane. Biochim. Biophys. Acta. 650: 128-150, 1981. Kostyuk, P. G., and O. A. Krishthal. Separation of sodium and calcium currents in the somatic membrane of mollusc neurones. J. Physiol. (Lond.) 270: 545-568, 1977. Krnjevic, K., E. uil and R. Werman. Evidence for Ca2+ -activated K conductance in cat spinal motoneurons from intracellular EGTA injections. Can. J. Physiol. Pharm. 53: 1214-1218, 1975. Krnjevic, K., E. Puil and R. Werman. Egta and motoneuronal after-potentials. J. Physiol. (Lond.) 275: 199-223, 1978. Krueger, B. K., R. W. Ratzlaff, G. R. Stricharz and M. P. Blaustein. Saxitoxin binding to synaptosomes, membranes and solubilized binding Sites from rat brain. J. Memb. Biol. 50: 287-310, 1979. Kusano, K. Influence of ionic environment on the relationship between pre- and postsynaptic potentials. J. Neurobiol. 1: 435-457, 1970. Kusano, K., D. R. Livengood and R. Werman. Correlation of transmitter release with membrane properties of the presynaptic fiber of the squid giant synapse. J. Gen. Physiol. 50: 2579-2601, 1967. Lehninger, A. L. Mitochondrial and calcium ion transport. Biochem. J. 119: 129-138, 1970. Leslie, 8. W., J. J. Woodward and R. E. Wilcox. Correlation of rates of calcium entry and endogenous dopamine release in mouse striatal synaptosomes. Brain Res. 325: 99-105, 1985. Llinas, R., and C. Nicholson. Calcium role in depolarization-secretion coupling: An aequorin study in squid giant synapse. Proc. Natl. Acad. Sci. 72: 187-190, 1975. Llinas, R., and M Sugimori. Electrophysiological properties of tg vitro purkinje cell dendrites in mammalian cerebellar Slices. J. Physiol. (Lond.) 305: 197-213, 1980. 108 Llinas, R., I. z. Steinberg and K. Walton. Presynaptic calcium currents in squid giant synapse. Biophys. J. 33: 289-322, 1981a. Llinas, R., I. Z. Steinberg and K. Walton. Relationship between presynaptic calcium current and postsynaptic potential in squid giant synapse. Biophys. J. 33: 323-352, 1981b. Llinas, R., and Y. Yarom. Properties and distribution of ionic conductances generating electroresponsiveness of mammalian inferior olivary neurons tg vitro. J. Physiol. (Lond.) 315: 569-584, 1981. Lowry, 0. H., N. J. Rosebrough, A. L. Farr and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 262-275, 1951. Lundh, H. Effects of 4-aminopyridine on neuromuscular transmission. Brain Res. 153: 307-318, 1978. Lundh, H., S. Leander and S. Thesleff. Antagonism of the paralysis produced by botulinum toxin in the rat. J. Neurosci. 32: 29-43, 1977. Luzzatto, L., D. Apirion and D. Schlessinger. Polyribosome depletion and blockage of the ribosome cycle by streptomycin in Escherichia coli. J. Molec. Biol. 42: 315-335, 1969. Manalis, R. S., and G. P. Cooper. Presynaptic and postsynaptic effects of lead at the frog neuromuscular junction. Nature 243: 354-356, 1973. Marban, E., and R. W. Tsien. Is the slow inward calcium current of heart muscle inactivated by calcium? Biophys. J. 33: 143a, 1981. Marchbanks, R. M. The uptake of [14C1choline into synaptosomes tg vitro. Biochem. J. 110: 533-541, 1968. Marchbanks, R. M. The activation of presynaptic choline uptake by acetylcholine release. J. Physiol. (Paris) 78: 373-378, 1982. Miledi, R. and C. R. Slater. The action of calcium on neuronal synapse in the squid. J. Physiol. (Lond.) 184: 473-498, 1966. Nachshen, D. A. Selectivity of the calcium binding site in synaptosome calcium channels. Inhibition of calcium influx by multivalent metal cations. J. Gen. Physiol. 83: 941-967, 1984. 109 Nachshen, D. A. The early time course of potassium- stimulated calcium uptake in presynaptic nerve terminals isolated from rat brain. J. Physiol. (Lond.) 361: 251-268, 1985a. Nachshen, D. A. Regulation of cytosolic calcium concentration in presynaptic nerve endings isolated from rat brain. J. Physiol. (Lond.) 363: 87-101, 1985b. Nachshen, D. A., and M. P. Blaustein. The effects of some organic "calcium antagonists" on calcium influx in presynaptic nerve terminals. Molec. Pharm. 16: 579- 586, 1979. Nachshen, D. A., and M. P. Blaustein. Some properties of potassium-stimulated calcium influx in presynaptic nerve endings. J. Gen. Physiol. 76: 709-728, 1980. Nachshen, D. A., and M. P. Blaustein. Influx of calcium, strontium and barium in presynaptic nerve endings. J. Gen. Physiol. 79: 1065-1087, 1982. Narahashi, T. Chemicals as tools in the study of excitable membranes. Physiological Rev. 54: 813-889, 1974. Narahashi, T., A. Tsunoo and M. Yoshii. Characterization of two types of calcium channels in neuroblastoma cells. J. Physiol. (Lond.), 1986 in press. Nikezie, G. S., and R. M. Metlas. Preincubation of synaptosomes in the presence of sodium affects Ca uptake. Molec. Biol. Rep. 10: 227-230, 1985. 2+ Nowyky, M. C., A. P. Fox and R. W. Tsien. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316: 440-443, 1985. Parsegian V. A. Considerations in determining the mode of influence of calcium on vesicle-membrane interaction. Soc. Neurosci. Symp. 2: 161-171, 1977. Penner, R., and F. Dreyer. Two different presynaptic calcium currents in mouse motor nerve terminals. Pflugers Arch. 406: 190-197, 1986. Pestka, S. Inhibitors of ribosome functions. Ann. Rev. Microbiol. 25: 487-562, 1971. Pittinger, C. B. pH and streptomycin influences upon ionic calcium in serum. Anesth. Anal. 49: 540-545, 1970. 110 Pittinger, C., and R. Adamson. Antibiotic blockade of neuromuscular function. Ann. Rev. Pharm. 12: 169-184, 1972. Pittinger, C. B., Y. Eryasa and R. Adamson. Antibiotic induced paralysis. Anesth. Anal. 49: 487-501, 1970. Prado, W. A., A. P. Corrado and R. F. Marseillan. Competitive antagonism between calcium and antibiotics at the neuromuscular junction. Arch. Int. Pharmacodyn. 231: 297-307, 1978. Richards, C. D., J. C. Metcalfe, G. A. Smith and T. R. Hesketh. Changes in free-calcium levels and pH in synaptosomes during transmitter release. Biochim. Biophys. Acta. 803: 215-220, 1984. Ritchie, A. K., and A. M. Goldberg. Vesicular and synaptosomal synthesis of acetylcholine. Sci. 169: 489-490, 1970. Rubbo, J. T., S. D. Gergis and M. D. Sokoll. Comparative neuromuscular effects of lincomycin and clindamycin. Anesth. Anal. 56: 329-332, 1977. Sanders W. F., and C. C. Sanders. Toxicity of antibacterial agents: Mechanism of action on mammalian cells. Ann. Rev. Pharm. Tox. 19: 53-58, 1979. Scott, I. D., K. E. O. Akerman and D. G. Nicholls. Calcium-ion transport by intact synaptosomes: Intrasynaptosomal compartmentation and the role of the mitochondrial membrane potential. Biochem. J. 192: 873-880, 1980. Sheu, S. -S., V. K. Sharma and A. Uglesity. Na+-Ca2+2+ exchange contributes to increase of cytosolic Ca concentration during depolarization in heart muscle. Am. J. Physiol. 250: C651-C656, 1986. Singh, Y. N., A. L. Harvey and I. G. Marshall. Antibiotic- induced paralysis of the mouse phrenic nerve- hemidiaphragm preparation, and reversibility by calcium and by neostigmine. Anesthesiology 48: 418- 424, 1978. Singh, Y. N., I. G. Marshall and A. L. Harvey. Depression of transmitter release and postjunctional sensitivity during neuromuscular block produced by antibiotics. Br. J. Anaesth. 51: 1027-1033, 1979. 111 Singh, Y. N., I. G. Marshall and A. L. Harvey. Pre- and post-junctional blocking effects of aminoglycoside, polymyxin, tetracycline and lincosamide antibiotics. Br. J. Anaesth. 54: 1295-1306, 1982. Sokoll, M. D. and S. D. Gergis. Antibiotics and neuromuscular function. Anesthesiology 55: 148-159, 1981. Standen, N. B. Properties of a calcium channel in snail neurones. Nature 250: 340-342, 1974. Stanley, E. F., and G. Ehrenstein. A model for exocytosis based on the opening of calcium-activated potassium channels in vesicles. Life Sci. 37:1985-1995, 1985. Steel, R. G., and J. H. Torrie. Principles and Procedures gt Statistics: 5 Biometrical Approach, second edition. McGraw-Hill Book Co., New York, 1980. Storm, D. R., K. S. Rosenthal and P. E. Swanson. Polymyxin and related peptide antibiotics. Ann. Rev. Biochem. 46: 723-763, 1977. Suszkiw, J. B., and M. E. O'Leary. Temporal characteristics of potassium-stimulated acetylcholine release and inactivation of calcium influx in rat brain synaptosomes. J. Neurochem. 41: 868-873, 1983. Suszkiw, J B., M. E. O'Leary, M. M. Murawsky and T. Wang. Presynaptic calcium channels in rat cortical synaptosomes: Fast-kinetics of phasic calcium influx, channel inactivation, and relationship to nitrendipine receptors. J. Neurosci. 6: 1349-1357, 1986. Suszkiw, J., G. Toth, M. Murawsky and G. P. Cooper. Effects of Pb and Cd on acetylcholine release and calcium movement in synaptosome and subcellular fraction from rat brain and Torpedo electric organ. Brain Res. 323: 31-46, 1984. Takeuchi, A., and N. Takeuchi. On the permeability of end- plate membrane during the action of transmitter. J. Tamaki, M. The effect of streptomycin on the neuromuscular junction of the frog. Brain Res. 265: 241-247, 1983. Tang, A. H. and L. A. Schroeder. The effect of lincomycin on neuromuscular transmission. Tox. Appl. Pharm. 12: 44-47, 1968. 112 Tillotson, D. Inactivation of Ca conductance dependent on entry of Ca ions in mulluscan neurons. Proc. Natl. Acad. Sci. 76: 1497-1500, 1979. Tsunoo, A., M. Yoshii and T. Narahashi. Two types of calcium channels in neuroblastoma cells and their sensitivities to cyclic AMP. Soc. Neurosci. Abst. 10: 527, 1984. Van der Kloot, W., and H. Kita. The effects of the "calcium-antagonist" verapamil on muscle action potentials in the frog and crayfish and on neuromuscular transmission in the crayfish. Comp. Biochem. Physiol. 50C: 121-125, 1975. Wang, T., M. M. Murawsky and J. B. Suszkiw. 2 ast-kinetic charaterization of voltage dependent Ca entry in synaptosomes. Biophys. J. 47: 433a, 1985. Washio, H. Presynaptic effect of streptomycin on the insect neuromuscular junction. Brain Res. 292: 382- 386, 1984. Weakly, J. N. The action of cobalt ions on neuromuscular transmission in the frog. J. Physiol. (Lond.) 234: 597-612, 1973. Wonnacott, S., R. M. Marchbanks and C. Fiol. Ca2+ uptake by synaptosomes and its effect on the inhibition of acetylcholine release by botulinum toxin. J. Neurochem. 30: 1127-1134, 1978. Wright, J. M., and B. Collier. Characterization of the neuromuscular block produced by clindamycin and lincomycin. Can. J. Physiol. Pharm. 54: 937-944, 1976a. Wright, J. M., and B. Collier. The site of the neuromuscular block produced by polymyxin B and rolitetracycline. Can. J. Physiol. Pharm. 54: 926- 936, l976b. Wright, J. M., and B. Collier. The effects of neomycin upon transmitter release and action. J. Pharm. Exp. Ther. 200: 576-587, 1977. Yeh, J. 2., G. S. Oxford, C. H. Wu and T. Narahashi. Dynamics of aminopyridine block of potassium channels in squid axon membrane. J. Gen. Physiol. 68: 519-535, 1976. Yoshii, M., S. Watabe and C. H. Wu. Differential blocking action of streptomycin on two types of calcium channels. Pharmacologist 28: 159, 1986. 113 Yu, C. and P.G. Nelson. The effect of BayK 8644 on synaptic transmission between mammalian spinal neurons in cell culture. Soc. Neurosci. Abst. 12: 824, 1986. "I71111111110117)“